INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, … · 2021. 3. 1. · INTEGRAL INSTITUTE OF...

Ref. No:- IIMS&R/DO/2021/ Date :- 05.02.21

Sports and Extra-curricular

activitiesOB AETCOM Medicine Pandemic module

8:00AM - 9:00AM 9:00AM - 10.00AM 10.00-11.00 AM 11.00-12.00 AM 12:00 - 1:00 PM 2:00 PM - 3:00 PM 3:00 PM - 4:00 PM 4:30 PM - 5:30 PM

01-03-21 Mon

PH 1.1.1 - PH 1.1.12

Define and describe the principles

of pharmacology and

pharmacotherapeutics

Lecture

MI 1.1.1

Introduction to medical

Microbiology and bacterial

taxonomy

Lecture

FM1.1

Demonstrate knowledge of

basics of Forensic Medicine

like

definitions of Forensic

medicine, Clinical Forensic

Medicine,

Forensic Pathology, State

Medicine, Legal Medicine

and Medical Jurisprudence

Lecture FM 1.1.1, FM1.2

Describe history of

Forensic Medicine FM 1.2.1

Lecture

PH1.9- Describe

nomenclature of drugs i.e.

generic, branded drugs

Lecture

Sports and Extra-curricular activities

02-03-21 Tue

CM 3.2.3 Describe water

purification on small scale and

water quality standard SGL (Batch

A to H)

PH1.11 Describe various

routes of drug

administration, eg., oral,

SC, IV, IM, SL

SGL (Batch A To H)

MI 1.1.7

Normal Microbial flora of

human body

SGL(Batch A to H)

MI 1.1.8 Culture

media and culture methods

SGL(Batch A to H)

--

03-03-21 Wed

PH1.3

Enumerate and identify drug

formulations and drug delivery

systems

Lecture

SU1.1 Describe Basic

concepts of homeostasis,

enumerate the metabolic

changes in injury and their

mediators.SU1.2 Describe

the factors that affect the

metabolic response to

injury

Lecture

--

04-03-21 Thu

PA 1.1

Describe the role of Pathologist in

diagnosis and management of

disease Lecture

MI 1.1.2 Introduction to

Parasitology,

classificattionand lab

diagnosis --Lecture

PA 1.2

Enumerate common terms

and definitions used in

Pathology Lecture

MI 1.1.10 Parasitological

agents-Peripheral Blood

Smear, Stool Concentration

Techniques, and Wet

Specimens

SGL(Batch A to H)

--

05-03-21 Fri

FM 2.1.1 to 2.2.1

Definition and Discription of death

and its types including somatic

molecular brain deatth , cortical

and brain stem death.

Lecture

PA 2.1

Cell injury and it's clinical

significance

Lecture--

PH4.1 Drug Administration using mannequins

DOAP (Batch A to H)

Clinical Posting Pharmacology

Community Medicine

PH 2.1- Demonstrate understanding of the use of

various dosage forms (oral/local/parenteral; solid/liquid)

DOAP (Batch A to H)

Clinical Posting

Clinical Posting

Clinical Posting

Microbiology Pathology Forensic Medicine

Date Day

Clinical Posting

Clinical Posting

Surgery

INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, INTEGRAL UNIVERSITY, LUCKNOW

TIME TABLE - MBBS SECOND PROFESSIONAL (Session 2020-21)

06-03-21 Sat

IM25.1 Describe and discuss the

response and the influence of host

immune status, risk factors and

comorbidities on zoonotic

diseases

(e.g. Leptospirosis, Rabies) and

non-febrile infectious disease (e.g.

Tetanus)

AETCOM:

Module 2.1.1

The foundations

of communication 2 -

Introductory SGL

PA 2.2

Etiology, mechanism

and morphology of

reversible and

irreversible injury

SGL (Batch A to H)

PH1.4.1 - PH1.4.5

Describe absorption,

distribution,

metabolism &

excretion of drugs

Lecture

PA 2.4

Types and mechanism of

different forms of cell death

and autolysis

Lecture

MI 1.1.3

Introduction to Virology,

Classification & Diagnosis,

Bacteriophage

Lecture

PA 1.3

Describe history and

evolution of human

Pathology

SDL (Batch A to H)


07-03-21 Sun

08-03-21 Mon

FM 2.2.2 to 2.3

Nattural and Un-natural and

Sudden natural death

Lecture

FM 1.3.1 -1.3.2 , 1.4.1 &

1.4.2

CRPC, IPC, IEA, Inquest

Different Ofences and

Court and their Power

SGL


09-03-21 Tue

MI 1.1.5 Morphology

and Physiology of bacteria

Lecture

MI 1.1.12 Viral

Models, Rapid tests, ELISA

SGL (Batch A to H)--

10-03-21 Wed

PH 1.4.6-1.4.10 Describe

absorption, distribution,

metabolism & excretion of drugs

Lecture

MI 1.1.4

Introduction to Mycology

classification and lab

diagnosis

Lecture

PA 2.3

Intracellular accumulation

of fats, proteins,

carbohydrates and

pigments

SGL (Batch A to H)

MI 1.1.9

Biochemicals/Automation/M

olecular methods

SGL(Batch A to H)

--

11-03-21 Thu

12-03-21 Fri

PA 2.7

Mechanism of cellular aging and

apoptosis

Lecture



metabolism & excretion of

drugs

Lecture

PA 2.5

Pathologic calcification and

gangrene

SGL (Batch A to H)

PH1.5.1-PH 1.5.6 Describe

general principles of

mechanism of drug action

SGL(Batch A to H)

--

13-03-21 Sat OG 5.1.1 Describe, discuss and identify pre-existing medical disorders and discuss their management

MI 1.1.11

Mycology agents-

KOH mount, LCB

mount and SDA

SGL (Batch A to H)

MI 1.1.6

Bacterial genetics

Lecture

PA 2.6

Cellular adaptations -

Atrophy, hypertrophy,

hyperplasia, metaplasia

and dysplasia

Lecture

PH1.5.7-PH1.5.12 Describe


mechanism of drug action

SGL(Batch A to H)


14-03-21 Sun

15-03-21 Mon

PA 3.1

Pathology of amyloidosis

Lecture

MI1.6.2 Methods of

Antimicrobial Susceptibility

Testing

SGL (Batch A to H)

FM 1.5.1 to FM 1.5.2

Summons, Conduct Money,

Witness SGL

PH1.5.13-PH1.5.18

Describe general principles

of mechanism of drug

action SGL(Batch A to H)


16-03-21 Tue

SU1.3 Describe basic concepts of

perioperative care.

Lecture

PH1.5.19-PH1.5.24

Describe general principles

of mechanism of drug

action

SGL(Batch A to H)

--

17-03-21 Wed




Lecture


purification on large scale

SGL (Batch A to H)

MI1.4.1 Classify and

describe the different

methods of Sterilization

Lecture

PA 3.2

Demonstration of

amyloidosis in pathology

specimens

DOAP

--

Sunday

MI 1.2.1

Perform and Identify the different causative agents of

infectious diseases by Gram stain

DOAP (Batch A to H)

AETCOM Module 2.1.2

The foundations of communication 2 -

Focused small group session

Sunday

Clinical Posting

Clinical Posting

Clinical Posting

MI1.2.3 Perform and Identify the different causative

agents of infectious diseases by

Stool routine microscopy- Protozoa

DOAP (Batch A to H)

Maha Shiv Ratri

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

PA 2.8

Demonstration of manifestation and

consequences of various forms of cell

injuries in gross and microscopic specimens

DOAP (Batch A to H)

18-03-21 Thu

MI1.4.2 Classify and describe the

different methods of Disinfection

Lecture

PA 4.1

General features of acute

and chronic inflammation

including vascular and

cellular events

Lecture

VI - General Surgery

(nesting)

MI1.6.3 Discuss the

monitoring of antimicrobial

therapy -MIC/MBC

SGL (Batch A to H)

FM1.5.3 to 1.5.4

Recording of Evidence,

Oath, Affirmation,

Examinattion in-chief,

Cross and Re-examinations

SGL

--

19-03-21 Fri

PH1.5.25-PH1.5.26 Describe

general principles of mechanism

of drug action Lecture

PH1.16-Describe

mechanism/s of action,

types, doses, side effects,

indications and

contraindications of the

drugs which act by

modulating autacoids,

including: anti-histaminics,

5-HT modulating

drugs, NSAIDs, drugs for

gout, anti-rheumatic drugs,

drugs for

migraine. Histamine &

Antihistamincs SGL (Batch

A to H)

PA 4.3

Chronic inflammation - non-

specific and granulomatous

Lecture

MI1.4.3 - MI1.5.1 Choose

the appropriate methods of

Sterilization used in

laboratory, clinical and

surgical practice SGL

(Batch A to H)

VI General Surgery

(nesting)

--

20-03-21 Sat

PA 4.2

Chemical mediators of acute

inflammation

Lecture

VI - General Surgery (nesting)

AETCOM Module 2.1.3

Skill lab sessions Sports and Extra-curricular activities

21-03-21 Sun

22-03-21 Mon




Lecture

PH1.16-

Describe mechanism/s of

action, types, doses, side

effects,

indications and


drugs which act by



5-HT modulating



drugs for migraine.

Prostaglandins

SGL (Batch A to H)

PH1.16-



effects,

indications and


drugs which act by



5-HT modulating



drugs for

migraine. NSAIDs (1)

SGL (Batch A to H)

MI1.4.4 - MI1.5.2 Choose

the appropriate methods of

Disinfection used in

laboratory, clinical and

surgical practice SGL

(Batch A to H)

VI General Surgery

(nesting)

Sports and Extra-curricular activitiesClinical Posting

Pandemic Module 2.1.1 to 2.1.4 Infection Conttrol:part-II Air borne precautions, contact precaution,infecttion control

committtee-4hours

Sunday

Clinical Posting

Clinical Posting

23-03-21 Tue

PA 5.1

Repair and regeneration including

wound healing

Lecture


PH1.16-Describe



indications and


drugs which act by



5-HT modulating



drugs for

migraine. NSAIDs (2)

SGL (Batch A to H)

PA 4.4

Demonstration of acute and

chronic inflammation in

gross and microscopic

specimens

DOAP (Batch A to H)

AETCOM Module 2.1.4

Discussion and closure--

24-03-21 Wed

PA 6.3

Pathogenesis of shock and its

clinical stages

Lecture


PH1.16-



effects,

indications and


drugs which act by



5-HT modulating



drugs for

migraine. 5HT and Migraine

Lecture

PA 6.1

Pathological aspects of

edema with clinical

correlation

Lecture

VI - General Medicine

(nesting)

MI1.3 Describe the

epidemiological basis of

common infectious

diseases -Bioterrorism

Lecture

HI Community Medicine

(nesting)

25-03-21 Thu

MI1.6.1 Describe the mechanisms

of Drug resistance

Lecture

HI Pharmacology (nesting)

PH1.13.1-PH1.13.6

Describe mechanism of


effects,

indications and

contraindications of

adrenergic and anti-

adrenergic

drugs. Adrenergic System

SGL (Batch A to H)

PH1.13.7-PH1.13.18



effects,

indications and



adrenergic

drugs. Adrenergic System

SGL (Batch A to H)

IM15.12 Enumerate the indications for

whole blood, component and platelet

transfusion and describe the clinical

features and management of a

mismatched transfusion

--

26-03-21 Fri

PA 6.2


hyperemia, congestion and

hemorrhage

Lecture

PH 1.25.1- PH1.25.6

Describe the mechanism/s

of action, types, doses,

side effects,

indications and


drugs acting on blood, like

anticoagulants,

antiplatelets, fibrinolytics,

plasma expanders (1)

Lecture

VI - Phy/Gen.med

--

MI1.2.3 Perform and Identify the different causative

agents of infectious diseases by Stool routine

microscopy- Helminths

DOAP (Batch A to H)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

27-03-21 Sat

OG5.1.2 Discuss evidence-based

intrapartum

care

PA 6.4

Normal haemostasis

and pathological

aspects of

thrombosis

Lecture

PH 1.25.7- PH1.25.12

Describe the

mechanism/s of

action, types, doses,

side effects,

indications and


the drugs acting on

blood, like

anticoagulants,

antiplatelets,

fibrinolytics, plasma

expanders ((2)

Lecture

VI - Phy/Gen.med

PH1.13.19-PH1.13.30

Describe mechanism

of action, types,

doses, side effects,

indications and



adrenergic

drugs. Anti

Adrenergic System

SGL (Batch A to H)

FM 1.5.5, 1.6.1 & 1.6.2

Conduct of Doctor in

Witness Box and Perjury

and Court Strictures

SGL

MI4.1.1 Anaerobes-

Clostridium perfringens

and other gas gangrene

causing Clostridium

Lecture

VI General Medicine

PA 6.5


embolism

SGL


28-03-21 Sun

29-03-21 Mon

30-03-21 Tue

31-03-21 Wed

1.7.1 to 1.7.2

Discription and Differences about

Dying declaration and Dying

deposition

Lecture

PH1.13.31-PH1.13.33



effects,

indications and



adrenergic

drugs. Antti Adrenergic

System

SGL (Batch A to H)

PA 6.6


ischaemia and infarction

along with its clinical

effects

SGL (Batch A to H)

PH 1.25.7- PH1.25.12

Describe the mechanism/s


side effects,

indications and


drugs acting on blood, like

anticoagulants,

antiplatelets, fibrinolytics,

plasma expanders.

Fibrinolytics (3)

Lecture VI - Phy/Gen.med


01-04-21 Thu

PA7.1

Neoplasia - Definition,

classification and general

characteristics

Lecture

PA 6.7

Demonstration of gross and

microscopic features of

infarction in a pathologic

specimen

DOAP (Batch A to H)

MI1.7.1 Antigen

Lecture

HI Pathology

PH1.13 Describe

mechanism of action,


indications and



adrenergic

drugs. SDL

--

02-04-21 Fri

03-04-21 Sat

PH1.6 Describe principles of

Pharmacovigilance & ADR

reporting systems

Lecture

MI4.1.3 Clostridium

difficileand non-

sporing anaerobes.

Lecture

VI General Medicine

PA 7.2

Molecular basis of

cancer

Lecture

FM 1.8.1 to 1.8.2

Latest decisions/

notification/ circulers

related to the

medicolegal practice

issued by the court.

SDL

SU3.1 Describe the

Indications and appropriate

use of blood and blood

products and complications

of blood transfusion.

Lecture


04-04-21 Sun

holi

Good Friday

AETCOM Module 2.2.1 Foundation

of bioethics Large

group session 1

Sunday

Clinical Posting

Clinical Posting

05-04-21 Mon

MI8.3 Describe the role of

Oncogenic viruses in the evolution

of virus associated malignancy

Lecture

VI General Medicine

HI Pathology


purification on small scale

and water quality standard

SGL (Batch A to H)

PH1.7 Define, identify and

describe the management

of adverse drug

reactions (ADR)

Lecture

IM 13.3 Describe the

relationship between

infection and cancers


06-04-21 Tue

PA 7.3

Discussion on the process of

carcinogenesis

Lecture

MI1.7.2 Antibody Lecture

HI Pathology

PA 7.4

Describe the effects of

tumor on the host including

para-neoplastic syndrome

SGL (Batch A to H)

FM 3.1.1 to 3.1.7

Identificaion Part-I

SGL

07-04-21 Wed

PH1.49 Describe mechanism of

action, classes, side effects,

indications

and contraindications of

anticancer drugs(1)

Lecture

MI1.8.2 Infecion

Lecture

VI Paediatrics

HI Pathology

PA 7.5

Immunology and immune

response to cancer

SGL

HI - Microbiology (sharing)

VI - Physiology (nesting)

PH1.49 Describe


classes, side effects,

indications


anticancer drugs(3)

Lecture

--

08-04-21 Thu

MI1.8.3 Describe the host Immune

response

Lecture

VI Paediatrics

HI Pathology

PH1.49 Describe


classes, side effects,

indications


anticancer drugs(2)

Lecture

PA 8.2

Exfoliative cytology -

Technique & stains used

SGL (Batch A to H)

VI - Surgery

PH 1.2.Describe the basis

of Evidence based

medicine and Therapeutic

drug monitoring

SGL(Batch A to H)

--

09-04-21 Fri OG 5.2 Determine maternal high risk factors and verify immunization status

PA 8.1

Diagnostic role of cytology

and its application in

clinical care

Lecture

VI - General Surgery

(nesting)

--

10-04-21 Sat

MI1.7.5 Complement system

Lecture

HI Pathology

CM 3.1 3.2 Describe

the health hazards of

water pollution and

describe the etiology

and basis of watter

borne diseases SGL

(Batch A to H)

MI 1.7.6 Structure

and function of

immune system

Lecture

HI Pathology

PH1.14.1 --1.14.4

Describe mechanism

of action, types,


indications and


cholinergic and

anticholinergic

drugs. Cholinergic

System

Lecture

MI1.8.1 Mechanism of

immunity

Lecture

VI Paediatrics

HI Pathology


11-04-21 Sun

12-04-21 Mon

PH1.14.5 --1.14.8 Describe

mechanism of action, types,


indications and contraindications

of cholinergic and anticholinergic

drugs. Cholinergic System

Lecture

PA 9.1

Principles and mechanisms

involved in immunity

SGL

HI - Micro (sharing)

VI - Pediatrics

MI1.10.1 Describe the

Immunological mechanism

in Hypersensitivity and the

lab methods used in

detection Lecture

VI Paediatrics

PA 9.2

Hypersensitivity reactions

and their mechanism

Lecture



PH3.4 To recognise and report an adverse drug

reaction

DOAP (Batch A to H)

PA 8.3

Demonstration of a cytology slide, its staining process

and its interpretation

DOAP (Batch A to H)

Sunday

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

13-04-21 Tue

PA 9.4

Autoimmunity and autoimmune

disorders

Lecture

SU4.2 Describe Clinical features,

Diagnose type and extent of

burns and

plan appropriate treatment.

SU4.3 Discuss the Medicolegal

aspects in burn injuries .FMT

nesting

Lecture



in Auto-immune disorders

and the lab methods used

in detection

Lecture

VI Paediatrics

Pandemic Module 2.2.1 exploratory and

interactive

theory session

( community medicine)

--

14-04-21 Wed

15-04-21 Thu

IM13.4 Describe the natural

history, presentation, course,

complications

and cause of death for common

cancers

PH1.50 Describe

mechanisms of action,


indications and


immunomodulators and

management of organ

transplant rejection

SGL (Batch A to H)

MI1.11 Describe the

Immunological mechanisms

of transplantation and

tumour immunity

Lecture

PA 9.3

HLA system and immune

principles involved in organ

transplantation

Lecture


--

16-04-21 Fri

MI 2.7.1 Describe the

epidemiology, etiology, evolution,

complication and opportunistic

infecions in case of HIV Lecture

HI Pathology

VI General Medicine

FM 3.1.8 to 3.1.10 and 3.2.1

to 3.2.2

Identificaion Part-II and

Identificaion Part-III

SGL

PA 9.6

Pathogenesis and

pathology of HIV and AIDS

Lecture


VI - Medicine (nesting)

PH1.48.16 to 1.48.20

Describe the mechanisms


side effects,

indications and


drugs used in UTI/ STD

and viral diseases including

HIV. Anti HIV drugs(1)

Lecture

--

17-04-21 Sat

OG 12.7 Describe and discuss

screening, risk factors,

management of

mother and newborn with HIV

MI2.7.2 Discuss the

lab diagnosis,

prevention and

principle of

management of HIV

SGL (Batch A to H)

HI Pathology

VI General Medicine

CM 7.2.1 & 8.1.1 AIDS-

Epidemiology, Prevention

and Conrol

Lectture

VI General Medicine

MI1.7.3 Antigen - Antibody

reaction 1 Lecture

HI Pathology

PA 9.5

Define and describe the

pathogenesis of systemic

Lupus Erythematosus

SGL (Batch A to H)

VI - Medicine


18-04-21 Sun

19-04-21 Mon

MI 1.7.4 Antigen - antibody

reaction 2 Lecture

HI Pathology

SU5.1 Describe normal wound healing

and factors affecting healing.

SU5.3 Differentiate the various types of

wounds, plan and observe

management of wounds

SU5.4 Discuss medico legal aspects of

wounds

Lecture

PH1.48.16 to 1.48.20



side effects,

indications and




HIV. Anti HIV drugs(2)

Lecture

PH1.14 Describe



indications and


cholinergic and

anticholinergic

drugs. SDL


Ambedkar Jayanti

PH1.14.9 --1.14.25 Describe mechanism of

action, types, doses, side effects,

indications and contraindications of

cholinergic and anticholinergic

drugs. Anti cholinergic SGL (Batch A- D)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Sunday

20-04-21 Tue

PH1.10 Describe parts of a

correct, complete and legible

generic

prescription. Identify errors in

prescription and correct

appropriately. Lecture


etiology and clinical

evolution of Malaria

Lecture

HI Pathology (sharing)


(nesting)

--

21-04-21 Wed

22-04-21 Thu

PA 9.7

Pathogenesis of common auto-

immune disorders Lecture

VI - Medicine

PA 10.1


malaria

SGL



MI2.5.4 Discuss the lab

diagnosis of Malaria

SGL (Batch A to H)

HI Pathology


(nesting)

PH1.47.1-PH1.47.4



side effects,

indications and


drugs used in malaria,

KALA-AZAR, amebiasis and

intestinal helminthiasis.

Antimalarial drugs (1) SGL

(Batch A to H) VI-Gen.Med.

--

23-04-21 Fri

IM 25. 2 Discuss and describe the

common causes, pathophysiology

and

manifestations of these diseases



in Immunodeficiency states

and the lab methods used

in detection

Lecture

VI Paediatrics

PH1.47.5-PH1.47.9



side effects,

indications and





Antimalarial drugs (2) SGL

(Batch A to H) VI-Gen.Med.

AETCOM FM 4.1 and 4.2

Medical Ethics and its

historical emergance.

Lecure

--

24-04-21 Sat

PA 13.1

Hematopoiesis and

extramedullary hematopoiesis

SDL


25-04-21 Sun

26-04-21 Mon

PH1.52 Describe management of

common poisoning, insecticides,

common sting and bites

Lecture

VI-Gen.Med.

PA 11.2

Pathology of tumor and

tumour like conditions of

infancy and childhood

SGL (Batch A to H)

VI - Pediatrics (nesting)

PA 11.3

Pathology of common

storage disorders of

infancy and childhood

SGL (Batch A to H)


MI8.1.3 Zoonotic disease -

Anthrax

SGL (Batch A to H)

VI General Medicine


27-04-21 Tue

PA 11.1

Common cytogenetic and

mutational disorders of childhood

Lecture


MI 1.9 Discuss the

Immunological basis of

vaccines and describe the

universal immunisation

schedule

Lecture

VI - Paediatrics (nesting)

--

Ram navami

MI2.6.1 Identify causative agents of malaria

DOAP (Batch A to H)

VI-General Medicine

AETCOM Module 2.2.2

Foundation of bioethics

Large group session 2

Pathology Formative Assessment Test

1

Sunday

Formative Assessment -1

Pharmacology

Clinical Posting

Clinical Posting

Clinical Posting

Pandemic Module 2.2.2 small group asignment emerging and reemerging

infectious disease

( community medicine)

Clinical Posting

Clinical Posting

28-04-21 Wed

OG 10.2 Enumerate the

indications and describe the

appropriate use of

blood and blood products, their

complications and management VI

PATHOLOGY


mehods used and

significance of assessing

the Microbial contamination

of food SGL

(Batch A to H)

PA 12.1

Pathology of disorders

caused by air pollution,

tobacco and alcohol

SGL

HI - Community Medicine

(Nestiing)

CM 3.4.1 concept of Solid

waste and

its management LECTURE

--

29-04-21 Thu

PH1.15 Describe mechanism/s of



of skeletal muscle relaxants

Lecture

VI Anaes,Phy

SU7.1 Describe the

Planning and conduct of

Surgical audit

Lecture


mehods used and

significance of assessing

the Microbial contamination

of water

SGL (Batch A to H)

CM 8.3.1 NACP

Lecture

VI-GENERAL MEDICINE,

PEDIATRICS

--

30-04-21 Fri

AETCOM FM 4.3 & 4.4

MCI & SMCI function and role and

indian medical register.

SGL

IM 15. 11 Develop, document and

present a treatment plan that includes

fluid

resuscitation, blood and blood

component transfusion, and specific

therapy for arresting blood loss


01-05-21 Sat

CM 2.5 Describe

poverty and social

security measures

and its relationship

to health and disease

SDL

PH 5.1Communicate with the

patient with empathy and

ethics on all

aspects of drug use SGL

PH 5.7 Demonstrate an understanding

of the legal and ethical aspects of

prescribing drugs SGL

PH 5.5 Demonstrate an understanding

of the caution in prescribing drugs

likely to produce dependence and

recommend the line of

management.

SGL (Batch A-D)

VI-Psychiatry.

02-05-21 Sun

03-05-21 Mon

PH1.59 Describe and discuss the

following: Essential medicines,

Fixed

dose combinations, Over the

counter drugs, Herbal medicines

Lecture

CM 7.2.2 & 8.1.2 Malaria

epidemiology, prevention,

conttrol, treatment

SGL (Batch A to H)

VI General Medicine

PA 12.2

Pathology of protein calorie

malnutrition and starvation

SGL (Batch A to H)

VI - Biochemistry,

Pediatric, Community

Medicine (nesting)

PH3.7 Prepare a list of

essential medicines for a

healthcare facility DOAP

(Batch A to H)


04-05-21 Tue

MI 8.1.1 Zoonotic diseases -

Plague Lecture VI

General Medicine

Formative Assessment

PA 12.3

Pathogenesis of obesity

and its consequences

SGL (Batch A to H)


PH1.61 Nutraceutical

SGL(Batch A to H)--

05-05-21 Wed

PA 22.1

Classification and description of

blood group systems

Lecture

MI8.1.2 Rickettsia Lecture

VI General Medicine

PA 22.2

Blood compatibility testing -

Principles, indications and

steps involved.

SGL (Batch A to H)

VI - Obs Gyn (nesting)

Pathology Formative

assesment 1

Feedback

--

06-05-21 Thu

OG 8.1 Enumerate, describe and

discuss the objectives of antenatal

care,

assessment of period of gestation;

screening for high-risk factors. VI

Community medicine

CM 10.5 UIP SGL

PA 22.5

Blood transfusion reactions

and its lab investigation

SGL (Batch A to H)


Microbiology

formative

assessment -1

feedback

--

07-05-21 Fri Jamat-ul-Wida

Clinical Posting

Clinical Posting

Sunday

Microbiology Formative Assesment-1

PH 4.2 Demonstrate the effects of drugs on blood

pressure (vasopressor

and vaso-depressors with appropriate blockers) using

computer

aided learning. (1) DOAP (Batch A to H)

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

PA 34.4

Identify, distinguish and describe

common tumors of the skin DOAP

08-05-21 Sat

PA 22.3

Blood components and their

clinical use Lecture

VI - Surgery, Medicine (nesting)

Pharmacology

Formative

Assessment-1

Feed back

MI 8.1.4

Zoonotic diseases-

Tularemia, KFD, Prions

SGL(Batch A to H)

VI General Medicine


09-05-21 Sun

10-05-21 Mon

PH1.17 Describe the mechanism/s

of action, types, doses, side

effects,


of local anesthetics.

Lecture

VI-Anes.

PA 22.4

Infections transmitted by

blood transfusion

SGL (Batch A to H)


MI 3.1.3

Enumerate and describe

the epidemiology,

pathogenesis and clinical

feature of microbial agents

causing Dysentery Lecture

VI General Medicine and

Paediatrics HI

Pathology (Sharing)

PH1.47 Describe the



indications and


drugs used in malaria, Kala

azar, amebiasis and


Anti Amoebic drugs

SGL (Batch A to H)


11-05-21 Tue

MI 8.16 Describe the

National health programs in the

prevention of common infectious

diseases Lecture


CM 3.1.1 Describe the

source, monitoring and

healh hazards of air

pollution

SGL (Batch A to H)


ENT

PA 22.6 Indications,

principle and procedure of

autologous blood

transfusion

SGL (Batch A to H)

PH1.55.1 - PH1.55.7

Describe and discuss the

following National Health

Programmes

including Immunisation,

Tuberculosis, Leprosy,

Malaria, HIV, Filaria, Kala

Azar, Diarrhoeal diseases,

Anaemia & nutritional

disorders, Blindness, Non-

communicable diseases,

cancer and Iodine

deficiency. SDL

--

12-05-21 Wed

PA 23.2

Body fluid analysis and abnormal

findings in various disease states

Lecture

MI 3.1.4

Discuss the diagnostic

modalities of microbial

agents causing Dysentery

SGL (Batch A to H)


Paediatrics HI

Pathology (Sharing)

--

13-05-21 Thu

SU7.2 Describe the principles and

steps of clinical research in

General

Surgery

Lecture

CM 3.4.2 human Excreta

and sewage disposal

SGL (Batch A to H)

PA 24.1

Pathological aspects and

clinical features of oral

cancers

SGL (Batch A to H)

VI - Dentistry (nesting)

PH1.55.8- PH1.55.12


following National Health

Programmes

including Immunisation,

Tuberculosis, Leprosy,

Malaria, HIV, Filaria, Kala

Azar, Diarrhoeal diseases,

Anaemia & nutritional

disorders, Blindness, Non-

communicable diseases,

cancer and Iodine

deficiency.

SDL

--

14-05-21 Fri

15-05-21 Sat

16-05-21 Sun

Clinical Posting

Sunday

PA 23.1

Abnormal urinary findings in various disease states.

Identification of common urinary abnormalities in a

clinical specimen

DOAP

PH2.4 Demonstrate the correct method of calculation of

drug dosage in patients including those used in special

situations DOAP

(Batch A to H)

AETCOM Module 2.3

Health care as a right

Participatory student seminar

Clinical Posting

Clinical Posting

Clinical Posting

IDUL FITR

17-05-21 Mon

PA 24.2 and 24.3

Pathological aspects of peptic

ulcer disease

Lecture


MI 3.6.1

Describe the etiology of

Acid Peptic Disease (APD)

and the clinical course.

Lecture VI

General Medicine

HI Pathology (Sharing) and

Pharmacology


18-05-21 Tue

IM 15.15 Describe and enumerate

the indications, pharmacology and

side

effects of pharmacotherapy of

acid peptic disease including

Helicobacter pylori

PH1.34.Describe the



indications and


drugs used as below:

1. Acid-peptic disease and

GERD

2. Antiemetics and

prokinetics

3. Antidiarrhoeals

4 . Laxatives

5. Inflammatory Bowel

Disease

6. Irritable Bowel

Disorders, biliary and

pancreatic diseases. Drugs

for APD (1)Lecture VI

Gen.Med.

--

19-05-21 Wed

AETCOM FM 4.10 & 4.29

Communicaion between Doctor,

Public and Media

Lecture

--

20-05-21 Thu

CM 19.1 & 19.2 Define and

describe the concept of essenttial

medicine list and its role in

primary health care HI-

Pharmacology (sharing) SGL

(Batch A to H)

PH1.34.Describe the



indications and




GERD

2. Antiemetics and

prokinetics

3. Antidiarrhoeals

4 . Laxatives


Disease

6. Irritable Bowel


pancreatic diseases. Drugs

for APD (2)

Lecture

VI Gen.Med.

MI 3.6.2

Discuss the diagnosis and

management of causative

agent of APD. SGL

(Batch A to H) VI

General Medicine


Pharmacology

PA 24.4


carcinoma of stomach

Lecture

VI - Surgery (nesting)

--

MI 3.2.4 Identify

the common etiologic agent of dysentery- Shigella

DOAP (Batch A to H) VI

General Medicine and Paediatrics

Formative assesment Pathology 2

Clinical Posting

Clinical Posting

Clinical Posting

Clinical PostingPandemic Module 2.2.3 and 2.2.4

SGD plenary session

21-05-21 Fri

MI 3.1.1 Enumerate

and describe the epidemiology,

pathogenesis and clinical feature

of microbial agents causing

Diarrhoea Lecture


Paediatrics HI

Pathology (Sharing)

PH1.34.Describe the



indications and




GERD

2. Antiemetics and

prokinetics

3. Antidiarrhoeals

4 . Laxatives


Disease

6. Irritable Bowel


pancreatic diseases.

Anidiarrhoeals

Lecture

VI Gen.Med.

PA 24.5

Pathologic features of

tuberculosis of the

intestine

SGL (Batch A to H)


FM 2.5.1 , 2.5.2, 2.6.1,

2.7.1, 2.7.2

Moment and modes of

deaths, Asphyxia and

syncope.&

Presumptions of death and

survivership. Suspended

animation

SGL

--

22-05-21 Sat

PA 24.7

Describe the etiology,

pathogenesis, pathology and

distinguishing features of

carcinoma of the colon

Lecture


PH1.34.Describe the

mechanism/s of


side effects,

indications and


the drugs used as

below:

1. Acid-peptic

disease and GERD

2. Antiemetics and

prokinetics

3. Antidiarrhoeals

4 . Laxatives

5. Inflammatory

Bowel Disease

6. Irritable Bowel


pancreatic diseases.

Drugs for

Inflammatory bowel

disease

SGL (Batch A to H)

PA 24.6.1 to PA

24.6.4

Pathological aspects

and distinguishing

features of

inflammatory bowel

disease

SGL (Batch A to H)


MI 3.1.2

Discuss the

diagnostic modalities

of microbial agents

causing Diarrhoea

SGL (Batch A to H)

VI General Medicine

and Paediatrics

HI Pathology

(Sharing)

PA 24.6.5 to PA 24.6.8


distinguishing features of

inflammatory bowel

disease SGL

(Batch A to H)



23-05-21 Sun

24-05-21 Mon

25-05-21 Tue

26-05-21 Wed

27-05-21 Thu

28-05-21 Fri

29-05-21 Sat

30-05-21 Sun

31-05-21 Mon

01-06-21 Tue

AITO

Jaundice 02

/06/2021

Wed

PA 25.1.1 to PA 25.1.3

Bilirubin metabolism.

Pathogenesis and types of

jaundice

Lecture

PA 25.1.4 to PA 25.1.6

Aetiological causes and lab

tests used for

distinguishing different

types of jaundice

SGL (Batch A to H)

PA 25.3.1 to PA 25.1.4

Viral and toxic hepatitis -

Pathology,complications

and consequences.

Lecture


OG 12.6. 1Describe the

clinical features, detection,

effect of pregnancy on the

disease and impact of the

disease on pregnancy HI

MEDICIE


Ist Terminal

1st Terminal

Budh Poornima

1st Terminal

MI 3.2.1

Identify the common etiologic agent of Diarrhea -Vibrio

cholerae

DOAP (Batch A to H) VI

General Medicine and Paediatrics

1 st Terminal Communiy Medicine theory

Sunday

Sunday

Clinical Posting

03-06-21 Thu

MI 3.7.1 Describe

the epidemiology of viral hepatitis

Lecture VI

General Medicine

HI Pathology (Sharing)

PH 1.48 Describe the



indications and




HIV. Drugs for hepatitis

Lecture

HI-Microbiology

PA 25.3.5 to PA 25.3.9

Viral and toxic hepatitis -

Pathology,complications

and consequences.

SGL


SU3.1 Describe the

Indications and appropriate

use of blood and blood

products and complications

of blood transfusion.

Lecture

--

04-06-21 Fri

IM 5.4 Describe and discuss the

epidemiology , microbiology

immunology

and clinical evolution of infective

(viral) hepatitis

PE 20.19 Neonatal hyperbilirubinemia

Lecture--

05-06-21 Sat

OG 12.6.2 complications and

management of liver disease in

pregnancy HI MEDICIE

SU28.12 Describe the

applied anatomy of biliary

system. Describe the

clinical features,

investigations and

principles of management

of

diseases of biliary system

Lecture


06-06-21 Sun

07-06-21 Mon

PA 25.2 Hepatic

failure Lecture

VI - Medicine, Surgery

PA 25.5


portal hypertension

SGL

VI - Medicine, Surgery

(nesting)

CM 3.6 National vector

borne disease control

programme

SGL (Batch A to H)

VI-MICROBIOLOGY

PA 25.4.1 o PA 25.4.4

Alcoholic liver disease

including cirrhosis

SGL

VI -- Medicine, surgery


08-06-21 Tue

FM 1.10 to 1.11

Cause of death in particular

scenario and cause of death

certificate by refering ICD-10

Code.

Lecture

PA 25.4.5 to PA 25.4.8


including cirrhosis

SGL

VI -- Medicine, surgery

--

09-06-21 Wed

PA 32.1

Thyroid swellings - Classification,

etiology, pathogenesis and

pathology

Lecture

VI - Anatomy, Physiology,

Medicine, Surgery (nesting)

FM 2.8.1 to 2.8.2

Postmortem changes

includings sighns of death,

postmortem lividity RM

SGL

.

--

10-06-21 Thu


genetic basis of some forms of

thyroid

dysfunction

MI 3.3.1

Describe the Enteric fever

pathogen and the clinical

course of the disease

Lecture VI

General Medicine


Pharmacology

--

1 st Terminal Communiy Medicine theory

Pathology

Formative assessment test 3

Sunday

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

PH 3.1 Write a rational, correct and legible generic

prescription for a given condition and communicate the

same to the patient for hepatitis (1).

DOAP (Batch A to H)

1 st Terminal Communiy Medicine practical

PA 25.6

Interpret liver function test report and viral hepatitis

serology panel.

DOAP (Batch A to H)


PH4.2 Demonstrate the effects of drugs on blood

pressure (vasopressor and vaso-depressors with

appropriate blockers) using computer aided learning.

Rabbit eye CAL DOAP (Batch A to H)

Aetcom Module 2.4.1

Working as a health care team

Tag along session 1

11-06-21 Fri

PA 32.2

Thyrotoxicosis - Pathological

aspects, laboratory and imaging

features. Lecture

VI - Physiology and Medicine

(nesting)

MI 3.3.2

Discuss the lab diagnosis

of Enteric fever

SGL (Batch A to H) VI

General Medicine


Pharmacology

PH1.42- Describe general

principles of Antimicrobial

chemotherapy.

Drugs for enteric fever

Lecture

HI-Micro ((Sharing)

Pandemic Module 2.3.1

describe specimen

selection collection

,transport,storage

required during

pandemic- Lecture

--

12-06-21 Sat

MI 3.5.1

Enumerate the

caustive agents of

Food poisoniong and

their clinical course

Lecture

VI General Medicine

HI Pharmacology

PA 32.3

Hypothyroidism -

Pathological aspects,

laboratory and

imaging features

SGL

VI - Physiology and

Medicine (nesting)

HI - Pharmacology

(sharing)

PH1.36.3 Describe the



indications and

contraindications of drugs

used in endocrine

disorders (diabetes

mellitus, thyroid disorders

and osteoporosis) Drugs

for Thyroid disorders (1)

Lecture

VI Gen.Med. (Nesting)

HI-Pathology((Sharing)


13-06-21 Sun

14-06-21 Mon

PH1.36.3 Describe the mechanism


effects,


of drugs used in endocrine

disorders (diabetes mellitus,

thyroid disorders and

osteoporosis) Drugs for Thyroid

disorders (2)

Lecture

VI Gen.Med. (Nesting)

HI--Pathology((Sharing)


describe the concept of

geriaric services along with

their health problems

LECTURE

MI 3.5.2

Discuss the lab diagnosis

of Food poisoning

SGL (Batch A to H)

VI General Medicine

HI Pharmacology

PA 32.5

Hyperparathyroidism -


laoratory features

SGL

VI - Physiology, Medicine

(nesting)


15-06-21 Tue

PA 32.8

Cushing's syndrome - Pathological

aspects and laboratory features

Lecture

VI -Physiology, Medicine (nesting)

PA 32.7

Adrenal insufficiency -


laboratory features

SGL

VI -Physiology, Medicine

(nesting)

--

16-06-21 Wed

PH1.38.1 Describe the mechanism


effects,


of corticosteroids.

Lecture

OG 8.2 Elicit document and present an

obstetric history including menstrual

history, last menstrual period, previous

obstetric history, comorbid

conditions, past medical history and

surgical history

--

Aetcom Module 2.4.2


Tag along session 2

PH3.5 To prepare and explain a list of P-drugs for a

given case/condition (1) DOAP (Batch A to H)

MI 3.4.1

Identify the different modalities for diagnosis of Enteric

fever in early disease-blood culture and widal

DOAP (Batch A to H)

VI General Medicine

HI Pathology

Sunday

Clinical Posting

Clinical Posting

Clinical Posting

MI 3.4.2 Identify the different

modalities for diagnosis of Enteric fever in late disease-

stool culture and urine culture

DOAP (Batch A to H)

VI General Medicine

HI Pathology

Clinical Posting

17-06-21 Thu

PA32.9

Adrenal neoplasms - Pathological

aspects and laboratory features

Lecture

VI - Anantomy, Physiology,

Medicine, Surgery

SU23.1 Describe the applied

anatomy of adrenal glands

SU23.2 Describe the

etiology, clinical features

and principles of

management of disorders of

adrenal gland

Lecture

--

18-06-21 Fri


chronic effects of diarrhea

including

malabsorption

PH1.38.1 Describe the



indications and


corticosteroids. Lecture

--

19-06-21 Sat

PH1.38.1 Describe

the mechanism of


side effects,

indications and


corticosteroids.

Lecture

PA 27.1.1 to 27.1.6

Various forms of

arteriosclerosis and

their pathological

aspects

SGL

VI -- Medicine

(nesting)

MI8.9.3 Discuss the method

of Collecion of sample -

Stool SGL(Batch A to H)

PH 1.42.1 o PH.42.6

General principles of

Antimicrobial

chemotherapy SGL (Batch

A to H)

FM 2.8.3 to 2.8.7

Diffferentiate PM stanning

witth Bruise and

congestion Rigermortis and

its medicolegal importance

in estimating TSD. SGL


20-06-21 Sun

21-06-21 Mon

PA 27.2

Aortic aneurysms -etiology,

dynamics and pathology

Lecture


PA27.1.7 to PA27.1.11

Various forms of

arteriosclerosis and their

pathological aspects

SGL

VI -- Medicine (nesting)

PH 1.42.7- PH.42.11

General principles of

Antimicrobial

chemotherapy SGL (Batch

A to H)

AETCOM Module 2.5.1

Bioethics continued – Case

studies on patient

autonomy and decision

making.

Introduction and group

formation


22-06-21 Tue

MI2.1.1 Describe the Etiological

agent in rheumatic fever Lecture

VI - Gen Mediciene HI- Patthology

(sharing)




indications and


drugs affecting renal

systems including

diuretics, antidiuretics-

vasopressin and

analogues. Diuretics (1)

Lecture

--

23-06-21 Wed

OG 8.7 Enumerate the indications

for and types of vaccination in

pregnancy

CM 12.3 & 12.4 prevention

of health problems of aged

ppopulattion and national

program for elderly.

LECTURE



types, doses, side

effects,indications and



systems including


vasopressin and

analogues. Diuretics (2)

SGL (Batch A to H)

MI2.2.1 Describe

theEtiological agents and

clinical features of Inf

Enocarditis Lecture VI -

Gen Mediciene HI-

Patthology (sharing)

--

Clinical Posting

Clinical Posting

Aetcom Module 2.4.3


Small group discussion

MI3.4.

MI3.2.5 Identify the common etiologyical agent of

dysentry -Entamoeba histolytica DOAP (Batch A to

H) VI General Medicine and Paediatrics

MI2.3 Identtify the microbial agentts causing Rheumatic

heart disease Streptococcus and enterococcus

DOAP(Batch A to H) VI - Gen Mediciene HI-

Patthology (sharing)

Clinical Posting

Clinical Posting

Clinical Posting

Sunday

24-06-21 Thu

PA 27.3

Heart failure - Pathological

aspects and complications

Lecture

VI - Medicine, Physiology

(nesting)

PA 27.4

Rheumatic fever -


complications

Lecture

VI - Gen Mediciene

(nesting)


MI 2.1.2 Discuss the lab

diagnosis of Rheumatic

fever - SGL (Batch A

to H) VI - Gen

Mediciene HI- Patthology

(sharing)



types, doses, side




systems including


vasopressin and

analogues. Antidiuretics

SGL(Batch A to H)

--

25-06-21 Fri

SU23.3 Describe the clinical

features, principles of investigation

and

management of Adrenal tumors

Lecture

PA 27.6

Infective endocarditis -


complications

Lecture



MI2.2.2Discuss the lab

diagnosis of Infecive

endocarditis SGL (Batch A

to H) VI - Gen

Mediciene HI- Patthology

(sharing)

Pathology

formative

assesment 2

Feedback

--

26-06-21 Sat

PH1.26 Describe mechanisms of



of the drugs modulating the

reninangiotensin

and aldosterone system.(1)

Lecture

VI Phy., Gen. Med.(Nesting)

PA 27.7

Pericardial effusion -


and complications

SGL

VI - Medicine

(nesting)

PA 27.4 and PA 27.6

Rheumatic fever and

endocarditis

SGL


27-06-21 Sun

AITO CAD Mon

IM 2.4 Discuss and describe the

pathogenesis natural history,

evolution

and complications of

atherosclerosis and IHD

PA 27.5.1 to PA 27.5.5

Pathology of coronary artey

disease Lecture

VI - Medicine

OG 12.4.1 Define, classify

and describe the etiology,

pathophysiology,

diagnosis, investigations,

criteria of heart diseases in

pregnancy HI MEDICINE

SU22.1 Describe the applied

anatomy and physiology of

thyroid

SU22.2 Describe the

etiopathogenesis of

thyroidal swellings

Lecture


29-06-21 Tue

PA 27.5.6 to PA 27.5.10

Pathology of coronary artery

disease

Lecture VI -

Medicine

PH1.28.1 -- 1.28.4 Describe

the mechanisms of action,


indications and


drugs used in

ischemic heart disease

(stable, unstable angina

and myocardial

infarction), peripheral

vascular disease (2) Lecure

VI Gen. Med.

PA 27.5.8 and PA 27.8.2

Lab diagnosis of coronary

artey disease

SGL

VI -- Physiology, Medicine

(nesting)

IM 2.5 Define the various

acute coronary syndromes

and describe their

evolution, natural history

and outcomesmedikine

--

Clinical Posting

Clinical Posting

FM 2.9.1 to 2.10.2 DOAP

Discribe putrefaction Mummification, Adipocere and

Maceration.Its MLI.

Discuss TSD.

Pharmacology Formative

Assessment -2

Clinical Posting

Clinical Posting

Sunday

30-06-21 Wed

OG 12.4.2 Describe adverse

effects on the mother and

foetus and the management during

pregnancy and labor, and

complications of heart diseases in

pregnancy HI MEDICINE

CM 8.2.1 & 7.2.5


epidemiology, conrol

measures including lab

ttestt at primary care level

for CAD

LECTURE

VI Gen Med.

--

01-07-21 Thu

SU22.4 SU22.5 & SU22.6 Describe

the clinical features, classification

and principles of

management of thyroid cancer

Describe the applied anatomy of

parathyroid

Describe and discuss the clinical

features of hypo - and

hyperparathyroidism and the

principles of their management

Lecture

PH1.28.5 -- 1.28.9 Describe

the mechanisms of action,


indications and


drugs used in

ischemic heart disease

(stable, unstable angina

and myocardial

infarction), peripheral

vascular disease (2) Lecure

VI Gen. Med.

CM 8.2.2 & 7.2.6



measures including lab test

at primary care level for

Hypertension

LECTURE

VI Gen Med.

IM 2.15 Discuss and

describe the medications

used in patients with an

acute coronary syndrome

based on the clinical

presentation

--

02-07-21 Fri

OG 12.1.1 Define, classify and

describe the etiology and

pathophysiology,

early detection, investigations;

of eclampsia.

OP 8.1 Discuss clinical feautres and

management of vascualar occlusions of

retina

LECTURE (ophthalmology)

--

03-07-21 Sat

AETCOM Module 2.5.2


studies on patient autonomy and

decision making.

Case introduction


04-07-21 Sun

05-07-21 Mon

PH1.26 Describe mechanisms of



of the drugs modulating the

reninangiotensin

and aldosterone system. (2)

Lecture

VI Phy,Gen.Med.(Nesting)

CM 7.2.4 & 8.1.4 Describe

the epidemiology,

mode of transmission and

measures

for preventtion

and control of

Viral hepatittis LECTURE

VI General Medicine


06-07-21 Tue

PH1.27 Describe the mechanisms


effects,


of antihypertensive drugs and

drugs used in shock. (1)

Lecture

VI Gen.Med.(Nesting)

PH1.27 Describe the



indications and


antihypertensive drugs and

drugs used in shock. (2)

Lecture

VI Gen.Med.

--

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

FM 2.11.1 to 2.11.4 DOAP

Describe and discuss autopsy procdures including

postmortem examination. Different types of

autopsies.Aims and Objectives of postmortem

examinations and Dissection and removal various organ

during autopsy.

Sunday

PA 27.8

Interpret abnormalities in cardiac function testing in

acute coronary syndromes

DOAP (Batch A to H)

VI - Physiology, Medicine (nesting)



same to the patient for CAD (2)

DOAP (Batch A to H)

AETCOM Module 2.5.3

Bioethics continued – Case studies on patient autonomy

and decision making.

Self-directed learning

Pandemic Module 2.3.2 to 2.3.4 sample collection, lab visit, group activity

MICROBIOLOGY

PH3.3-Perform a critical evaluation of the drug

promotional literature(1) DOAP (Batch A to H)

07-07-21 Wed

PA 27.9

Cardiomyopathies - Pathological

aspects and complications

Lecture

VI - Medicine, Physiology (nesting)

MI 8.9.1 Discuss the of

Blood collection of

microbial agent SGL(Batch

A to H)

CM 7.2.3 & 8.1.3 describe

the epidemiology, mode of

transmission of Amoebiasis

and Ascariasis SGL (Batch

A to H)

PH 1.42 Describe general

principles of Antimirobial

chemotherapy. B lactam

antibiotics (1) SGL (Batch A

to H)

--

08-07-21 Thu

SU2.1 Describe Pathophysiology

of shock, types of shock &

principles of

resuscitation including fluid

replacement and monitoring.


features of shock and its

appropriate treatment.

Lecture

PA 27.10

Cardiovascular syphilis -


complications

SGL



CM 8.3.2 Iodine deficiency

disorder and its

programme


PEDIATRICS LECTURE


principles of Antimirobial

chemotherapy. B lactam

antibiotics (2) SGL (Batch A

to H)

--

09-07-21 Fri

MI 8.2.1 Describe

Parasitological Oppurtunistic

infecions Lecture

VI General Medicine


IM 16.6 Distinguish between

diarrhea and dysentery

based on clinical

features

--

10-07-21 Sat

AETCOM Module 2.5.4



decision making Anchoring

Lecture

PH 1.42 Describe


Antimirobial

chemotherapy.

Cephalosporins SGL

(Batch A to H)

MI 8.2.2 Fungal

Oppurtunistic infecions

Lecture

VI General Medicine


PH 5.5 Demonstrate an

understanding of the

caution in prescribing

drugs

likely to produce

dependence and

recommend the line of

management.

SGL (Batch A to H)

VI-Psychiatry.

MI 3.1.

Enumerate and describe

the epidemiology,

pathogenesis and clinical

feature of microbial agents

causing Dysentery Lecture


Paediatrics HI

Pathology (Sharing)


11-07-21 Sun

12-07-21 Mon

PH1.29 Describe the mechanisms


effects,


of the drugs used in

congestive heart failure (1)

Lecture


PA 28.1

Normal histology of the

kidney

Lecture


13-07-21 Tue

PA 28.2

Clinical syndromes of renal

disease - Pathological aspects,

clinical, laboratory findings and

complications

Lecture

PH1.29 Describe the



indications and


drugs used in

congestive heart failure (2)

Lecture


MI 8.6.1

Biomedical Waste

Management

SGL (Batch A to H)


(sharing)

CM 14.1,14.2,14.3 classify

hospital waste

SGL (Batch A to H)

HI Microbiology

--Clinical Posting

MI 3.2.3 Identify the

common etiologic agent of diarrhoea -Giardiasis

DOAP (Batch A to H)

VI General Medicine and Paediatrics

Formative assesment microbiology 2

FM 2.12 to 2.14

Describe the legal requirments to conduct postmortem

examination and procedures.

Discuss commen instuments used during autopsy.

Discibe and discuss obscure autopsy.

Examinations of clothing and viscera.

Chemical analysis and PM artifacts.SGL

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Sunday

14-07-21 Wed

OG 12.1.2 Describe principles of

management of hypertensive

disorders of pregnancy and

eclampsia, complications of

eclampsia HI MEDICINE

MI 8.6.2 Needle

stick injury

SGL (Batch A to H)


(sharing)

PA 28.3

Acute renal failure -


clinical, laboratory findings

and complications

SGL

VI -General Medicine

(nesting)

Pharmacology

Formative

Assessment -2

Feed back

--

15-07-21 Thu

PA 28.4

Chronic renal failure -

Pathological aspects, clinical,

laboratory findings and

complications

Lecture

VI -General Medicine (nesting)

PH1.29 Describe the



indications and


drugs used in

congestive heart failure

SDL

--

16-07-21 Fri

SU29.1 Describe the causes,

investigations and principles of

management

of Hematuria

Lecture

PA 28.5.1 to PA 28.5.4

Glomerulonephritis -



and complications

Lecture


--

17-07-21 Sat

AETCOM 2.5.5



decision making

Case resolution

Pandemic

Module 2.3.5

Discussion and

closure

PA 28.5.5 to PA 28.5.9

Glomerulonephritis -



and complications

SGL


FM 2.15

Describe special protocols

for conduction of medico-

legal atupsies in case of

death in costudy or folloing

violation of human right as

NHRC guide lines. SGL

MI 7.3.1 UTI Lecture

VI Gen medicine Sports and Extra-curricular activities

18-07-21 Sun

19-07-21 Mon

PA 28.13

Renal stone disease and

obstructive uropathy -

Pathological aspects, clinical,


complications

Lecture


MI 7.3.2 UtI SGL Ecoli

VI Gen medicine



types, doses, side





HIV

Drugs for UTI and STD

SGL(Batch A to H)

HI-Microbiology (Sharing)

IM 10.8 Classify, describe and discuss

the significance of proteinuria in CKD--

20-07-21 Tue

PA 28.10

Pathology of chronic

pyelonephritis and reflux

nephropathy

Lecture

VI- Medicine (nesting)

HI - Pharmacology (sharing)

MI8.9.2 Sample processing

Urine SGL--

21-07-21 Wed

22-07-21 Thu

23-07-21 Fri

24-07-21 Sat

Clinical Posting

Clinical Posting

PH 2.3 Demonstrate the appropriate setting

up of an intravenous drip in a simulated

environment DOAP (Batch A to H)

MI 3.2.2 ECOLI DOAP

VI Gen medicine & Pediatrics

Clinical Posting FORMATIVE ASSESSMENT -1 COMMUNITY MEDICINE

MI 8.7.1

Universal precaution and Spill Management

DOAP (Batch A to H)

VI General Surgery HI

Community Medicine

Clinical Posting

Clinical Posting

Sunday

IDulAZHA

25-07-21 Sun

26-07-21 Mon

PH1.42 Describe general


chemotherapy. Flouroquinolones

Lecture

PA 28.12

Pathology of cystic disease

of the kidney

SGL

VI - Medicine, Pediatrics

(nesting)

--

27-07-21 Tue

OG 6.1 Describe, discuss and

demonstrate the clinical features

of

pregnancy, derive and discuss its

differential diagnosis, elaborate

the principles underlying and

interpret pregnancy tests

PH1.42 Describe general


chemotherapy.

Tetracycline and

chloramphenicol. Lecture

PA 28.11

Vascular disease of the

kidney - Pathological

aspects, clinical,


complications

SGL


PH1.53-Describe heavy

metal poisoning and

chelating agents.

SGL (Batch A to H)

--

28-07-21 WedCM 10.5.1

Immunizing agents and AEFI SDL

PA 28.15

Thrombotic angiopathies -



and complications

SGL

VI -Medicine (nesting)

PH1.60-Describe and

discuss

Pharmacogenomics and

Pharmacoeconomics.

SGL 9Batch A to H)

MI7.3.3 Schistosoma SGL

VI Gen Medicine--

29-07-21 Thu

PA 28.14

Renal tumors - Pathological

aspects. presenting features and

progression

Lecture


MI6.1.1. Corynebacterium

Lecture

MI8.9.7 Sample collecttion

for URTI SGL

PH3.6 Opimize interacion

wih Pharma representaive

SGL(Batch A to H)

--

30-07-21 Fri


features, investigations and

principles of

management of congenital

anomalies of genitourinary system

Lecture

MI6.1.2 Viral causes URTI

SGL

VI - Gen. Medicine (nesting)

PA 26.2

Lung abscess -



and complications

SGL



MI6.1.4 LRtI SGL

VI - Gen. Medicine (nesting) --

31-07-21 Sat

IM 3.1 Define,

discuss, describe and

distinguish

community acquired

pneumonia,

nosocomial

pneumonia and

aspiration pneumonia

PH1.42 Describe


Antimicrobial

chemotherapy.

Macrolides and

miscellaneus

antimicrobials.

SGL (Batch A to H)

PA 28.16


presenting features of

urothelial tumors

Lecture


--

01-08-21 Sun

Clinical Posting

Clinical Posting

Clinical Posting

Pandemic Module 2.4.3 visit tto PHC

(COMMUNITY MEDICINE)

AETCOM 2.6.2

Bioethics continued: Case studies on autonomy

and decision making

Self directed learniing

PH3.1 Write a rational, correct and legible generic


same to the patient (3)

DOAP (Batch A to H)

Clinical Posting

Clinical Posting

Sunday

Sunday

02-08-21 Mon

PA 26.1

Pneumonia - Pathological

aspects, clinical, laboratory

findings and complications

Lecture



PH1.33 Describe the



indications and


drugs used in cough

(antitussives, expectorants/

mucolytics)

SDL

VI-Resp.Med.

--

03-08-21 Tue

PH 1.32.Describe the

mechanism/s of action, types,

doses, side effects,indications

and contraindications of drugs

used in bronchial asthma

and COPD (1)

Lecture

VI--Resp.Med.

MI 6.1.5 C pneumophila

SGL

VI Gen medicine(NESTING)

PA 26.3

Pathology of obstructive

airway disease (OAD) and

bronchiectasis

Lecture

HI - Micro, Pharma

(sharing)

VI - Medicine Physiology

(nesting)

PH 1.32.Describe the


types, doses, side



used in bronchial asthma

and COPD (1)

Lecture

VI--Resp.Med.

--

04-08-21 Wed

PA 26.4.1 to PA 26.4.5

Pathology of pulmonary

tuberculosis Lecture

HI -Micro, Pharma (sharing)


MI6.1.3 TB Lecture

VI Gen medicine

PA 26.4.6 to PA 26.4.10

Pathology of pulmonary

tuberculosis

SGL

HI - Micro and Pharma

(sharing)


PH 1.44 Describe the first

line antitubercular dugs,

their mechanisms of action,

side effects and doses (1).

Lecture

VI-Resp.Med.

--

05-08-21 Thu

AETCOM 2.6.3

Bioethics continued: Case studies

on autonomy and decision making

Anchoring Lecture

PH1.44-Describe the first

line antitubercular dugs,

their mechanisms of

action, side effects and

doses. (2)

Lecture

VI-Resp.Med.

OG 8.8 Enumerate the

indications and describe

the investigations

including

the use of ultrasound in

the initial assessment

and monitoring in

pregnancy

FM 2.16.1

Describe and discuss

examination of mutilated

bodies or fragments chart

bone and bundle of bones.

SGL--

06-08-21 Fri

PH1.45 Describe the dugs used in

MDR and XDR Tuberculosis

Lecture

VI-Resp.Med.

HI-Microbiology

PA 26.5

Occupational lung disease -


complications.

SGL

VI - Community Medicine,

Medicine (nesting)

MI 6.1.6 Mycoplasma

SGL

VI Gen medicine

Formative assesmen

test 3

Feedback

--

07-08-21 Sat

AETCOM 2.6.4



Discussion and closure of case

SU29.3 Describe

the Clinical

features,

Investigations and

principles of

management of

urinary tract

infections

Lecture

Forensic Medicine

Formative assesment--

08-08-21 Sun

Clinical Posting

MI6.3.2 AFB staining DOAP

VI Gen medicine

Clinical Posting

Clinical Posting

Pandemic module 2.4.1, 2.4.2, 2.4.4 EXPLORATORY SESSION, SGD, DISCUSSION

AND CLOSURE

(COMMUNITY MEDICINE)

Clinical Posting

Clinical Posting

Sunday

09-08-21 Mon

PA 26.6 and 26.7

Pathology of tumors of the lung

and pleura

Lecture


Medicine (nesting)

MI6.1.8 Deep Mycosis SGL --

10-08-21 Tue

PH1.51 Describe occupational and

environmental pesticides, food

adulterants, pollutants and insect

repellents

Lecture

PA 26.6 and 26.7

Pahology of tumors of the

lung and pleura SGL


Medicine (nesting)

--

11-08-21 WedMI 6.1.1 to 6.1.3

Corynebacterium/TB SDL

PA 29.2


carcinoma of the penis

SGL


PA 29.3


benign prostatic

hyperplasia

Lecture


PH 1.13 Describe



indications and



adrenergic

drugs. Drugs for BPH SGL

(Batch A to H)

Sharing with Pathology

--

12-08-21 Thu

AETCOM 2.7.1



Introduction of case

PH 1.40 Describe



indications and

contraindications of 1.

Drugs used in the

treatment

of infertility, and 2. Drugs

used in erectile

dysfunction. Drugs used in

erectile dysfunction and

inferliliy

SGL (Batch A to H)

VI-Obs.Gynae

CM 11.2 Describe the role,

benefits and functioning of

the employees state

insurance scheme

SGL

PA 29.5

Pathology and progression

of prostatitis

SGL


FM 4.18.4 to 4.19.2

13-08-21 Fri

AETCOMFM 4.11.1 to 4.11.3 and

4.18.1

Euthanasia and defination and

types of medical negligence

Lecture

MI7.1.1 Chlamydia

Lecture

VI Gen SURGERY

--

14-08-21 Sat

PA 29.1

Pathology of testicular tumors,

diagnostic tests and progression

Lecture


PH1.37 Describe the

mechanisms of


side effects,

indications and


the drugs used as sex

hormones, their

analogues and

anterior Pituitary

hormones. anterior

Pituitary hormones

Lecture

MI7.2.1 Syphilis

Lecture

VI-Obs.Gynae,derma

OG 9.1.1 Classify,

define and discuses

the aetiology and

management of

abortions including

threatened,

incomplete,

inevitable,

CM 8.1.5 epidemiology of

Emerging and re-emerging

infections

SGL (Batch A to H)

MICROBIOLOGY AND

PPATHOLOGY (NESTING)

VI Gen Med.

--

15-08-21 Sun

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Independence Day

MI6.3.1 LRTI DOAP agents gram stain

FM 2.17.1 and 2.18.1 to 2.18.3

Describe and discuss exhumation, Crime scene

investigation and Discuss the crime scene visit, the

duties and responsibilites of doctors on crime scene and

the reconstruction of sequence of events after crime

MI1.2.2 ZN stain DOAP

Pharmacology Formative Assessment -

3

16-08-21 Mon

PH 1.37 Describe the mechanisms


effects,


of the drugs used as sex

hormones, their analogues and

anterior Pituitary hormones.Sex

hormones

Lecture

PA 30.1

Carcinoma of the cervix-

Epidemiology, pathological

aspects and progression

Lecture

VI - Obs and Gynaec

(nesting)

MI 7.2.3 Trichomonas

SGL

VI Obs.Gynae,derma



types, doses, side



drugs used as sex

hormones, their analogues

and anterior Pituitary

hormones.Sex hormones

SDL

--

17-08-21 Tue


features, investigations and

principles of

management of hydronephrosis

Lecture

PA 30.3

Leiomyomas and

leiomyosarcomas

SGL

VI - Obs and Gynaec

(nesting)

PA 30.2

Carcinoma of the

endometrium - Pathology,

diagnosis and progression

Lecture

VI - Obs and Gynaec

(nesting)

PH 1.39 Describe



indications and

contraindications the drugs

used for contraception.

SGL(Battch A-D)

VI-Obs Gynae

--

18-08-21 Wed

PA 29.4

Carcinoma of the prostate -

Pathology, diagnostic tests and

progression

Lecture


OG 9.1.2 Classify, define

and discuses the aetiology

and management of

abortions including missed

and septic

PA 30.4.1 to PA 30.4.3

Ovarian tumors -


SGL

VI - Obs and Gynaec

(nesting)

PA 30.4.4 to PA 30.4.6

Ovarian tumors -


SGL

VI - Obs and Gynaec

(nesting)

--

19-08-21 Thu

20-08-21 Fri

Pandemic Module 2.5.1 EXPLORATORY AND

INTERACTIVE SESSION NEW DRUG

DEVELOPMENT

PHARMACOLOGY/MEDICINE

CM Formative assesment --

21-08-21 Sat

PA 30.5

Pathology of

gestational

trophoblastic

neoplasms.

SGL

VI - Obs and Gynaec

(nesting)

--

22-08-21 Sun

23-08-21 MonAITO week Diabetes

mellitus

PA 32.4.1 to PA 32.4.6

Pathology of diabetes

mellitus - Part 1

Lecture


CM 8.2.4 & 7.2.8





for DIABETES MELLITUS

Lecture

VI Gen Med.

IM 11.1 Define and classify

diabetes --

Muharram

Raksha Bandhan

AETCOM 2.7.2

Bioethics continued: Case studies on autonomy and

decision making

SDL

Pathology Formative assesment

test 5

Pandemic Module 2.5.2 SGD

NEW DRUG DEVELOPMENT


Pandemic Module 2.5.3 VISIT TO PHARMACEUTICAL

FIRM


Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

24-08-21 Tue

PH1.36 Describe the mechanism


effects,





osteoporosis) Insulin

Lecure

VI--Gen.Med.

PA32.4.7 to PA 32.4.11

Pathology of diabetes

mellitus - Part 2

Lecture


CM 8.2.5 & 7.2.9





for OBESITY

Lecture

VI Gen Med.

PH1.36 Describe the



indications and


used in endocrine

disorders (diabetes


and osteoporosis) Oral

hypoglycemic drugs

Lecure

VI--Gen.Med.

--

25-08-21 Wed

PH1.36 Describe the mechanism


effects,





osteoporosis) Insulin analogues

Lecture

VI-Gen.Med.

SU24.2 Describe the

clinical features, principles

of investigation, prognosis

and management of

pancreatic endocrine

tumours

Lecture

--

26-08-21 Thu


pathogenesis and temporal

evolution of

microvascular and macrovascular

complications of diabetes

OG 12.3.1 Define, classify

and describe the etiology,

pathophysiology,

diagnosis, investigations,

criteria,of diabetes in

pregnancy

SU24.3 Describe the

principles of investigation

and management of

Pancreatic disorders

including pancreatitis and

endocrine tumors.

Lecture

CM 8.3.3 National

Programme

for Prevention & Control of

Cancer, Diabetes,

Cardiovascular Disease

and Stroke

Lecture

VI General Medicine

--

27-08-21 Fri

PE 33.4 DIABTES MELLITUS IN CHILDREN

(PEDIATRICS)

CM 5.1 Describe the common

sources of various nutrients and

special

nutritional requirements

according to age, sex, activity,

physiological

conditions SDL

OP 8.3 & 8.4 Retinal changes in

diabetic retinopathy and its

management

lecture (ophthalmology)

Reserve --

28-08-21 Sat

AETCOM 2.7.3



Anchoring Lecture

IM11. 2 Describe and discuss

the epidemiology and

pathogenesis and risk

factors and clinical evolution

of type 1 diabetes

CM 8.1.6 Antimirobial

Resisttance

HI Mircobiology

LECTURE

OG 12.3.2 Discuss

adverse effects on the

mother and

foetus and the

management during

pregnancy and labor,

and

complications of

diabetes in pregnancy

Pathology Formative

Assesment Test 5

Feed back

CM 19.3 Describe

counterfiet medicine and

its prevention SGL (Batch A

to H)

HI- PHARMACOLOGY

--

29-08-21 Sun

30-08-21 Mon

Clinical Posting



same to the patient for diabetes (4)

DOAP (Batch A to H)

Clinical Posting

Janmasthmi

Clinical Posting

Clinical Posting

Sunday

31-08-21 Tue

SU6.1 Define and describe the aetiology

and pathogenesis of surgical

Infections

Lecture

MI 7.1.2 Neisseria

SGLVI-GEN SURGERY

PH1.36- Describe the


types, doses, side



used in endocrine

disorders (diabetes


and osteoporosis). Drugs

for Diabetes Mellitus

SDL

CM 8.2.3 & 7.2.7


epidemiology, control



for STROKE

LECTURE

VI Gen Med.

--

01-09-21 Wed

PH 1.18 Describe the mechanism/s


effects,


of general anaesthetics, and

preanesthetic

medications(1)

Lecture

VI-Anaes.

PA 30.6

Pathology of cervicitis

SGL VI -

Obs and Gynaec (nesting)

--

02-09-21 ThuMI 1.4.1 to 1.4.2 Sterilization and

disinfection SDL

PA 30.7 and PA 30.8

Pathology of adenomyosis

and endometriosis

SGL

VI - Obs and Gynaec

(nesting)




indications and


general anaesthetics, and

preanesthetic

medications(2)

Lecture

VI-Anaes.

AETCOM FM 4.18.2 to

4.18.5

Description of deffirent

kinds of negligence,

vicarious libality and Res

ipsa loquitor.

Defence against

negligence.

SGL

--

03-09-21 Fri

IM 21.1 Describe the initial

approach to the

stabilisation of the patient who

presents with poisoning

PA30.9

Pathology of endometrial

hyperplasia

SGL

VI - Obs and Gynaec

(nesting)

MI7.1.3 Enterobius SGL

VI-GEN SURGERY

Pharmacology

Formative

Assessment -3

Feed back

--

04-09-21 Sat

AETCOM 2.7.4



Discussion and closure of case

PH1.23 Describe the

process and

mechanism of drug

deaddiction

Lecture

MI 7.2.2 Hemphilus

SGL

VI-OBS GYNAE AND

DERMATOLOGY

PA 31.1 and PA 31.4

Pathology of benign

breast diseases and

gynaecomastia - Part

1

SGL

VI - Surgery, Anatomy

(nesting)

PH1.20 Describe the

effects of acute and

chronic ethanol intake.

PH1.21-Describe the

symptoms and

management of methanol

and ethanol poisonings

SGL(Batch A to H)

Pandemic module 2.5.4

DISCUSSION

NEW DRUG

DEVELOPMENT

PHARMACOLOGY/MED

ICINE

PA10.4

Pathology of common

bacterial, viral, protozoal

and helminthic diseases

SDL

--

05-09-21 Sun

06-09-21 Mon

07-09-21 Tue

08-09-21 Wed

09-09-21 Thu

10-09-21 Fri

11-09-21 Sat

12-09-21 Sun

13-09-21 Mon

MI 1.2.2 ZN staning DOAP

Iind TerminaL

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Iind TerminaL

Sunday

Sunday

14-09-21 Tue

OG 9.5 Describe the

etiopathology, impact on maternal

and fetal health and

principles of management of

hyperemesis gravidarum

PA 31.1 and PA 31.4

Pathology of benign breast

diseases and

gynaecomastia - Part 2

SGL

VI - Surgery, Anatomy

(nesting)

--

15-09-21 Wed



effects,


of the drugs which act on CNS,

(including anxiolytics, sedatives &

hypnotics, anti-psychotic, anti

depressant drugs, anti-maniacs,

opioid agonists and antagonists,

drugs used for neurodegenerative

disorders, anti-epileptics drugs)

Sedatives and hypnotics(1)

Lecture

VI-Psychiatry,Phy.

MI 5.1.1 - Meningitis

(Group B streptococcus)

Lecture

VI GEN.MEDICINEAND

PAEDIATRICS

HI PATHOLOGY

PA 31.2

Pathology of carcinoma of

breast

Lecture


PH1.37 Describe the


types, doses, side



drugs used as sex

hormones, their analogues

and anterior Pituitary

hormones. Drugs for Ca

breast SGL

--

16-09-21 Thu

ClholiSU6.2 Enumerate

Prophylactic and therapeutic

antibiotics

Plan appropriate management

Lecture

PA 31.2

Pathology of carcinoma of

breast

SGL


--

17-09-21 Fri

MI 5.1.2 Neisseria

Lecture VI GEN.MEDICINE AND

PAEDIATRICS

HI PATHOLOGY

PH1.19 Describe the



indications and


drugs which act on CNS,

(including anxiolytics,

sedatives & hypnotics, anti-

psychotic, anti depressant

drugs, anti-maniacs, opioid

agonists and antagonists,

drugs used for

neurodegenerative

disorders, anti-epileptics

drugs) Sedatives and

hypnotics (2)

Lecture

VI-Psychiatry,Phy.

MI8.9.6 Sample collecion

CSF SGL

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Anti-psychotics

Lecture

VI-Psychiatry,Phy.

--

Formative assesment MICRO

Clinical Posting

Clinical Posting

2 nd terminal Community Medicine

PA 31.3

Describe and identify morphologic and microscopic

features of carcinoma of the breast

DOAP (Batch A to H)


18-09-21 Sat

CM 11.1 Enumerate and Describe

the presentting features of

pattients with occupational illness

including agriculture

LECTURE

MI5.1.3 Meningittis

(Polio) LectureVI

GEN.MEDICINE

PAEDIATRICS

HI PATHOLOGY

PA 35.1

Etiology, types,

pathogenesis and

CSF findings in

meningitis

Lecture

VI - Medicine

(nesting)

HI- Microbiology

(sharing)

MI5.1.4 Meningitis

(Herpes) LecureVI

GEN.MEDICINE

,Paediatrics

HI PATHOLOGY

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Anti-psychotics

SDL


pharmacology, dose,

adverse reactions and

regimens

of drugs used in the

treatment of bacterial,

tubercular and viral

meningitis

FM 4.21 & 4.8

Describe product liablity

and medical indemnity

insurance and consumer

protection act 1986,

workmen compensation act

and ESI act.

SGL

--

19-09-21 Sun

20-09-21 Mon

PA 35.2.1 to PA 35.2.3

Pathology of CNS tumours - Part 1

Lecture


PA 35.1

Pathology of different

forms of meningitis

SGL


HI- Microbiology (sharing)

--

21-09-21 Tue

MI 5.1.5 Meningitis (Rubella)

Lecture

VI GEN.MEDICINE, Pediatrics

HI Pathology

PA 35.2.4 to PA 35.2.7

Pathology of CNS tumours -

Part 2

SGL


MI5.1.6 Meningitis

(Acanthameba,toxoplasma)

Lecture

VI GEN.MEDICINE,

Pediatrics

HI Pathology


the epidemiology, mode of

transmission of

meningococcal meningitis

SGL Batch (A-D)

VI Gen-Medicine

--

22-09-21 Wed




contraindications of the drugs

which act on CNS, (including

anxiolytics, sedatives & hypnotics,

anti-psychotic, anti depressant




disorders, anti-epileptics drugs) .

Anti-depressants(1)

Lecture

VI-Psychiatry,Phy.

MI 5.1.7 Meningitis

(Crypptococcus) Lecture

VI GEN.MEDICINE,

Pediatrics

HI Pathology

--

Clinical Posting

Clinical Posting

Clinical Posting

PA 35.3

Identify the etiology of meningitis based on given CSF

parameters

DOAP (Batch A to H)


HI- Microbiology (sharing)

Pathology Formative assesment 6

Sunday

23-09-21 Thu

OG 9.3 Discuss the aetiology,

clinical features, differential

diagnosis of

acute abdomen in early pregnancy

(with a focus on ectopic

pregnancy) and enumerate the

principles of medical and surgical

management

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Anti-

depressants(2)

Lecture

VI-Psychiatry,Phy.

--

24-09-21 Fri

PA 34.2

Pathological aspects of basal cell

carcinoma of skin

Lecture

VI - Dermatology (nesting)

MI 5.2.1 Encephalitis

( Dengue) LectureLecture

VI GEN.MEDICINE,

Pediatrics

HI Pathology

--

25-09-21 Sat

AETCOM 2.8.2 What does

it mean to be family member of a

sick patient? Large

Group Discussions with patients’

relatives

CM 7.2.6 & 8.1.8

describe the

epidemiology, mode

of transmission of

STDs.

Lecture

VI Skin & VD

Pathology

Formative assesment 6

Feedback

--

26-09-21 Sun

27-09-21 Mon

PA 33.1

Pathology of osteomyelitis

Lecture

VI - Anatomy, Orthopaedics

(nesting) HI -

Microbiology (sharing)

MI4.2.1 Bone and joint

infecions

(Stapphylococcus) Lecture

VI ORTHOPAEDICS

--

Clinical Posting

Clinical Posting

Clinical Posting MI 6.2 URTI DOAP

AETCOM 2.8.1 What

does it mean to be family member of a sick patient?

Hospital visit and interviews

Pharmacology Formative Assessment -

4

PH4.2 Demonstrate the effects of drugs on

blood pressure (vasopressor and vaso-

depressors with appropriate blockers) using

computer aided learning (2). Frog Heart

DOAP (Batch A to H)

PH 1.12 Calculate the dosage of drugs using appropriate

formulae for an individual patient, including children,

elderly and patient with renal

dysfunction. DOAP(Batch A to H)

Sunday

28-09-21 Tue

PH 1.36 Describe the mechanism


effects,





osteoporosis).Calcium metabolism

and drugs for osteoporosis.

Lecture

VI--Gen.Med.

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Opiod agonists(1)

SGL (Batch A to H)

VI-Psychiatry,Phy.

PA 33.2.1 to PA 33.2.4

Pathology of primary and

metastatic ttumour of bone -

Part 1

SGL

VI - Orthopaedics (nesting)

MI 4.2.2 Bone infecions

(Pseudomonas) Lecture

VI Orthopaedics

--

29-09-21 Wed

MI 4.3.3 Skin and sof ttisue

infection (Superficial

mycoses)Lecture

VI dermatology &GEN.surgery

MI 8.9.4 Collection of

sampple (Pus) SGL

PA 33.2.5 to PA 33.2.8

Pathology of primary and

metastatic ttumour of bone -

Part 2

SGL

VI - Orthopaedics (nesting)

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Opiod angonists

(2)

SGL (Batch A to H)

VI-Psychiatry,Phy.

--

Clinical Posting

Clinical Posting

30-09-21 Thu

SU9.1 Choose appropriate

biochemical, microbiological,

pathological,

imaging investigations and

interpret the investigative data in

a

surgical patient

PH1.19 Describe the


types, doses, side









drugs used for

neurodegenerative


drugs) . Opiod antagonists

SGL (Batch A to H)

VI-Psychiatry,Phy.

01-10-21 Fri

AETCOM 2.8.4

What does it mean to be family

member of a sick patient?

Discussion and closure


the syndromic management

of STDs.

Lecture

VI Skin & VD

MI 4.2.3 Bone and jointt

infection

((Mycetoma)Lecture

VI orthopaedics

PA 33.3

Pathology of soft tissue

tumors

SGL

VI - Orthopedics (nesting)

02-10-21 Sat

03-10-21 Sun

04-10-21 Mon

AETCOM FM 4.19.1 to 4.19.2

Define and Described conscent its

types. Rules of consent in relation

to age emergency mental illness

and alcohol intoxication. Lecture

IM 7.5 Describe and

discriminate acute,

subacute and chronic

causes of

joint pain

PA 33.5

Pathology of rheumatoid

arthritis

SGL


PH1.16 Describe



indications and


drugs which act by



5-HT modulating



drugs for

migraine.Drugs for RA

Lecture

HI-Pathology (Sharing)

VI-Gen.Med.

--

Clinical Posting MI 1.2.3 Sool microscoppy DOAP

Clinical Posting

Clinical Posting

Gandhi Jayanti

05-10-21 Tue

PH 1.19 Describe mechanism/s of



of the drugs which act by

modulating autacoids, including:

anti-histaminics, 5-HT modulating

drugs, NSAIDs, drugs for gout,

anti-rheumatic drugs, drugs for

migraine.Drugs for Gout

Lecture

VI-Gen.Med.


Assessment Feed back - 4

MI 4.3.1 Skin and soft

tissue infection (Leprosy(

Lecture)

VI DERMA AND

GEN.MEDICINE

PA10.3

Pathogenesis and

pathology of leprosy

Lecture





types, doses, side



antileprotic drugs.SGL

(Batch A to H)

HI-Pathology

(Sharing),Micro.(Nesting)

VI--Dermatology

--

06-10-21 Wed

OG 14.1 Enumerate and discuss

the diameters of maternal pelvis

and types VI ANATOMY

MI 8.1.6 Zoonotic ds

(Echinococcus) SGL

VI GEN. MEDICINE

PA10.2

Pathogenesis and

pathology of cysticercosis

SGL






indications and




intestinal helminthiasis.Anti-

helminthic drugs

SGL (Batch A to H)

HI-Pathology

(Sharing),Micro.(Nesting)

VI-Gen.Med.

--

07-10-21 Thu MI 8.1.1 Plague SDL

PA 33.4

Pathology of Paget's

disease of bone

SGL

VI - Orthopedics (nesting)

--

08-10-21 Fri

PA 32.6

Pathology of pancreatic cancer

Lecture

VI - Surgery

FM 4.20 & 4.24

Describe therapeutic

privilage malingring,

therapeutic missadventure,

Professional secrecy,

Humen experimentation.

SGL

MI 4.3.4 Skin infecions

(Dermatophytes) LECTURE

VI- Dermattology,Gen

Surgery


principles of antimicrobial

chemotherapy.Anti-fungal

drugs(1) SGL (Batch A to H)

HI-Microbiology (Sharing)

--Clinical Posting

Microbiology Formative assesment

Clinical Posting

Clinical Posting

Clinical Posting

09-10-21 Sat

CLSU9.2 Biological basis for early

detection of cancer and

multidisciplinary

approach in management of

cancer

Lecture

PA 36.1

Patholgy of

retinoblastoma

SGL

VI - Opthalmology

MI4.3.5 Skin

infections Sub

cutaneous mycoses

LectureVI-

Dermattology,Gen

Surgery

PH 1.42 Describe


antimicrobial

chemotherapy.Anti-

fungal drugs(2)

SGL (Batch A to H)

HI-Microbiology

(Sharing)

Mi 4.3.6 Skin infections Pox

virus Lecture

VI- Dermattology,Gen

Surgery




indications and





psychotic, antidepressant



drugs used for

neurodegenerative


drugs).Drugs used for

neuro degeneraive

disorders

SGL (Batch A to H)

VI-Psychiatry, Phy.

PA18.1

Causes of leucocytosis,

leucopenia, lymphocytosis

and leukemoid reactions

SGL

--

10-10-21 Sun

11-10-21 Mon

CM 8.3.5 UNIVERSAL

IMMUNZATION PROGRAMME

SGL

clinical lecure

MI4.1.2 Clostridium tetani

and Clostridium botulinum

Lecture

VI General Medicine

MI 8.9.5 Collection of

sample for fungus SGL--

12-10-21 Tue

Mi 4.3.6 Skin infections Pox virus

Lecture

VI- Dermattology,Gen Surgery




indications and





psychotic, antidepressant



drugs used for

neurodegenerative


drugs).Drugs used for

neuro degeneraive

disorders

SGL (Batch A to H)

VI-Psychiatry, Phy.

PA18.1

Causes of leucocytosis,

leucopenia, lymphocytosis

and leukemoid reactions

SGL

--

Clinical Posting

Clinical Posting

Sunday

13-10-21 Wed



effects,




hypnotics, anti-psychotic,

antidepressant





drugs).Antiparkinsonian drugs

Lecture

VI-Psychiatry,Phy.

MI2.5.5 Filariasis Lecture

HI--Patthology(sharing)

VI-- Gen medicine

PA 18.2.1 to PA 18.2.4

Acute leukemias

Lecture

PA19.1

Causes and differentiating

features of

lymphadenopathy

SGL

VI -Surgery (nesting)

--

14-10-21 Thu

15-10-21 Fri

16-10-21 Sat

17-10-21 Sun

18-10-21 Mon

PA 18.2.5 to PA 18.2.8

Chronic leukemias

Lecture




indications and


drugs used in the

management of

dyslipidemias(1)

SGL (Batch A to H)

VI-Gen.Med.

--

19-10-21 Tue

20-10-21 Wed


pathophysiology and

manifestations of

malignant causes of fever

including hematologic and lymph

node

malignancies

PA 19.2

Pathology of tuberculous

lymphadenitis

SGL


--

21-10-21 ThuMI 2.5.8 Common parasites

Fasciola hepatica SDL

PA 19.6

Causes of splenomegaly

SGL

VI - General Surgery,

Medicine (nesting)

--

22-10-21 Fri

FM 2.20.1 to 2.20.3

Define classify, describe

medicolegal interpretation of PM

findings.

Lecture




indications and


drugs used in the

management of

dyslipidemias(2)

SGL (Batch A to H)

VI-Gen.Med.

--

Clinical Posting

Clinical Posting

MI 2.6.2 Filariasis DOAP

VI-- Gen medicine

PA19.3

Identify and describe features of tuberculous

lymphadenitis in a gross and microscopic specimen

DOAP



appropriate blockers) using computer aided learning (3)

DOAP(Batch A to H)

FM 2.21.1 to 2.21.5 DOAP

Hanging strangulation including clinical findings cause

of death PM findings preservation and dispatch of

ligature material.

Differentiate between hanging and strangulation.

Dussehra

EID-E-MILAD UN NABI

Clinical Posting

Clinical Posting

Clinical Posting

Sunday

23-10-21 Sat

MI2.5.7 Commom parasites

prevelant in India Lecture


VI-- Gen medicine

PH 1.58 Describe

drugs used in Ocular

disorders (Glaucoma)

SGL(Batch A to H)

VI-Ophthal.

PH1.43 Describe and

discuss the rational

use of antimicrobials

including antibiotic

stewardship program

SGL

PA 19.4.1 to PA

19.4.2

Pathology of non-

Hodgkin's lymphoma

SGL


SU10.1 Describe the

principles of perioperative

management of common

surgical procedures

Lecture

MI 8.6.3 Antimicrobial

stewardship SGL

CM 8.3.6 RNTCP

SGL--

24-10-21 Sun

25-10-21 MonMI 2.5.9 Ebola and Marburg fever

SDL

PH 1.58 Describe drugs

used in Ocular disorders

SGL(Batch A to H)

VI--Ophthal

--

26-10-21 Tue


pathophysiology and

manifestations of

inflammatory causes of fever

PA 19.4.3 to PA 19.4.4

Pathology of non-Hodgkin's

lymphoma

SGL


--

27-10-21 Wed

SU10.2 Describe the steps and

obtain informed consent in a

simulated

environment

Lecture

PA 19.4.5 to PA 19.4.7

Pathology of Hodgkin's

lymphoma

SGL


--

28-10-21 Thu

MI 2.5.1 Kala azar Lecture

HI--Patthology(nesting)

VI-- Gen medicine

PH1.47 Describe the



indications and




intestinal helminthiasis

Drugs for Kala azar SGL

(Batch A to H)

--

29-10-21 Fri

PA 21.1

Normal hemostasis

SDL

MI2.5.2 Kala azar SGL

HI--Patthology(nesting)

VI-- Gen medicine

--

30-10-21 Sat MI 2.7.1 HIV SDL

PA 21.2

Pathology of vascular

and platelet disorders

including ITP and

haemophilia

SGL

VI - Pediatrics

(nesting)

IM 4.6Discuss and describe

the pathophysiology and

manifestations of

malaria

--

31-10-21 Sun

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

MI 8.11 Performance of lab ess DOAP

Pathology Formative assesment 7

MI 8.10 Methods of collecion of sample DOAP

PA 19.5

Identify and describe the features of Hodgkin's

lymphoma in a gross and microscopic specimen

DOAP

PH 3.2 Perform and interpret a critical appraisal (audit)

of a given prescription (1)

PA 19.7

Identify and describe the gross specimen of an enlarged

spleen

DOAP

PH3.5 To prepare and explain a list of P-drugs for a

given case/condition DOAP (1)

Sunday

Sunday

01-11-21 Mon



effects,




hypnotics, anti-psychotic,

antidepressant




disorders, anti-epileptics drugs)

Anti-anxiety,antimanic drugs

Lecture

SU11.1 Describe principles

of Preoperative

assessment.

Lecture

FM 2.22.1 to 2.22.5

Trumatic Asphyxia,

Obstruction of nose and

mouth, Suffocation and

sexual asphyxia - Describe

and discuss

patthophysiology, c/f, PM

findings and medicolegal

aspects.

SGL

Pathology Formative

assesment 7

Feedback

--

02-11-21 TueCM 8.3.9 NRHM

SGL

PH5.3 Motivate patients

with chronic diseases to

adhere to the prescribed

management by the health

care provider

SGL (Batch A to H)

--

03-11-21 Wed

PA 21.3

Differentiate platelet from clotting

disorders based on the clinical

and hematologic features

Lecture

VI Medicine (nesting)

MI 8.12 ppatientt

confidentiality SGL--

04-11-21 Thu

05-11-21 Fri

06-11-21 Sat

07-11-21 Sun

08-11-21 Mon

11.4 CM 11.4 Describe the

principle of ergonomics in

healtth ppreservation

SGL

PA 21.4

Pathology of disseminated

intravascular coagulation

Lecture


--

09-11-21 Tue

CM 8.3.7 NATIONAL PROGRAM

FOR CONTROL OF BLINDNESS

SGL

PA 21.5

Pathology of Vitamin K

deficiency SGL


--

10-11-21 Wed

PH1.54 Describe vaccines and

their uses

SDL

FM 2.23.1 to 2.23.5

Describe and discuss

types, pathophysiology,

clinical features, PM

findings and medico legal

aspects. Diatom test,

Gettler test., AM PM

drowning, Fresh water and

salt water.SDL

PA 23.3.1

Semen analysis

SGL

PA 23.3.2

Thyroid function tests

SGL

--

11-11-21 Thu

IM 9.12 Describe, develop a

diagnostic plan to determine the

aetiology of

anemia

CM 8.3.8 National leprosy

eradication program

SGL

--

PA 20.1

Describe the features of plasma cell myeloma

DOAP




DOAP(Batch A to H)

Clinical Posting

Clinical Posting

Clinical Posting

Deepawali

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

MI 8.14 Pattient confedentialiy DOAP VI AETCOM

PH3.5-To prepare and explain a list of P-drugs for a

given case/condition (3)

DOAP (Batch A to H) Revisioin


Assessment- 5

Sunday

AITO

AnemiaFri

PA 13.1

Normal hematopoiesis and

extramedullary hematopoiesis

SDL

PY2.1 and 2.2 - Describe the

composition of blood components

and synthesis and function of

hemoglobin

PA 13.3

Classification of anemia

Lecture

PY 2.3 and BI 6.12 -

Describe variants of

haemoglobin and their

physiological/ pathological

relevance.

IM 9.2 - Prevelance of each

of the ca

uses of anemia

PY2.5 Different types of

anemia

MI 2.4........ Pathogenesis

of anemia caused due to

infectious agents

--

13-11-21 Sat

PA 13.4

Laboratory investigation in a case

of anemia

Lecture

IM 9.6 and 9.12 - Appropriate

diagnostic plan and work up

based on presumed etiology of

anemia

Linker case Part 1

OG 12.2.1 Define, classify and

describe the etiology,

pathophysiology,

diagnosis, investigations of

anemia in pregnancy

PE 29.1 Approach to child with

anaemia Lecture

CM 5.6 important

national nutritional Programs including

the Integrated Child

Development Services Scheme (ICDS)

etc LECTURE

PA 14.1

Iron metabolism

SGL

BI 6.11 - Metabolism of

haem PE

13.1 - RDA, nutritional

sources of iron

PA 14.2

Etiology, investigations and

differential diagnosis of

microcytic hypochromic

anemia

SGL

IM 9.8 - Various tests for

iron deficiency anemia

MI2.4..... Pathogenesis of

MH by infectious agents

--

14-11-21 Sun

15-11-21 Mon

PA 15.1

Normal Vitamin B12 metabolism

and pathological aspects of

vitamin B12 deficiency

SGL

IM 9.9 - Interpretation of

hemogram, red cell indices and

B12 and folate levels

BI 6.5 - Vitamins

MI2.4..... Pathogenesis of

macrocytic anemia caused by

infectious agents

PA 15.2 and 15.4

Laboratory investigations

in a case of different forms

of macrocytic anemia.

SGL

IM 9.9 - Tests for B12 and

folate

--

16-11-21 Tue

MI 2.4.1 Microbial agents in

anemia Lecture


VI-- Gen medicine


indications for blood

transfusion and the

appropriate

use of blood components

--

17-11-21 Wed

PA 16.1

Classification and introduction to

hemolytic anemia Lecture

VI - Biochemistry, General

Medicine BI

5.2 Structure - function

relationship of hemoglobin in

hemoglobinopathies

PA 16.2 and PA 16.4


laboratory investigation of

hemolytic anemia

SGL

BI 5.2 and MI 9.5

--

PA 16.3 and PA 16.5

Describe the pathogenesis, features, hematologic

indices and peripheral blood picture of sickle cell

anemia, thalassemia and other hemolytic anemia

SGL

IM 9.5 Differential diagnosis of anemia based on clinical

features BI 5.2

MI 2.4.......... Pathogenesis of hemolytic anemia caused

by infectios agents

Sunday

PA 14.3

Identify and describe the peripheral smear in microcytic

anemia

DOAP (Batch A to H)

IM - 9.10

PA 15.3

Identify and describe the peripheral blood picture of

macrocytic anemia

DOAP

Clinical Posting

Clinical Posting

PA 13.5

Perform, Identify and describe the peripheral blood

picture in anemia

DOAP (Batch A to H)

VI - IM 9.7 Meaning and utility of various components of

the hemogram report

Clinical Posting

Clinical Posting

18-11-21 Thu

PA 17.1

Pathology and laboratory

investigations in a case of aplastic

anemia. Lecture

PA 17.2

Bone marrow aspiration

and biopsy - Indications

and findings

SGL

IM 9.11 Interpret results of

bone marrow

Linker case - Part B

PA 13.2 Role

of anticoagulants in

hematology practice

SGL

VI - Medicine

--

19-11-21 Fri

20-11-21 Sat



effects,


of drugs used in hematological

disorders like:

1. Drugs used in anemias

2. Colony Stimulating factors

Drugs used in anemia

Lecture

VI--Gen.Med., Phy.

PA 16.7

Describe the correct

technique to perform

a cross match

SGL

OG 12.2.2 Describe adverse effects

on the mother and foetus

and the management during

pregnancy and labor, and

complications of anemia in

pregnancy

--

21-11-21 Sun

22-11-21 Mon MI 4.2.1 Staphylococcus SDL




indications and


used in hematological

disorders like:

1. Drugs used in anemias

2. Colony Stimulating

factors

Colony Stimulatting factors

Lecture

VI--Gen.Med., Phy.

--

23-11-21 Tue

PH1.22- Describe drugs of abuse

(dependence, addiction,

stimulants,

depressants, psychedelics, drugs

used for criminal offences)

Lecture

VI-Psychiatry (Nesting)

HI-Forensic Med.(Nesting)

MI2.4.2 Anemia SGL


VI-- Gen medicine

--

24-11-21 WedCM 8.3.10 NUHM

SGL

Pharmacology

Formative Assessment -

5 Feed

back

--

25-11-21 Thu

MI4.1.2 Clostridium tetani and

Clostridium botulinum

Lecture

VI General Medicine

PH1.8-Identify and describe

the management of drug

interactions

SGL ((Batch A to H)

--

26-11-21 FriCM 8.3.11 Janani Suraksha Yojana

SGL

CM 8.3.13 IMNCI (Age upto

2 mnths to 5 years)

SGL

--MI3.2.5 E hisolytica DOAPClinical Posting

Clinical Posting Microbiology Formtive assesment 5

PA 16.6

Prepare a peripheral blood smear and

identify hemolytic anaemia from it

DOAP

Formative assesment Theory - AITo

anemia



same to the patient for anemia (5)

DOAP(Batch A to H)

Clinical Posting

Clinical Posting

Formative assesment Skill - AITo anemia

Clinical Posting

PH 3.2 Perform and interpret a critical appraisal (audit)

of a given prescription (2)

Sunday

Guru Nanak Jayanti

Clinical Posting

27-11-21 Sat

PH1.56-Describe basic aspects of

Geriatric and Pediatric

pharmacology. Drug for Pediatric

Pharmacology (2) Lecture

VI-Pediatrics (Nesting)

PA 7.1

General

charactteristics of

neoplasia - Revision

SGL

CM 8.3.12 IMNCI (Age

upto 2 months)

SGL

Microbiology

Formatave

assesment Feedback

4 and 5

CM 19.1 & 19.2 Define and describe the concept of International health and Describe roles of various international health agencies SGL

MI 8.1.5 Zoonotic

disease- Brucella

SGL(Batch A to H)

VI General Medicine

PH1.4.Pharmacokinetics

SDL--

28-11-21 Sun

29-11-21 Mon MI 6.1.3 TB SDL

CM 8.3.14 Ayushman

bharat yojana

SGL

--

30-11-21 Tue

PA 13.4

Investigation in a case of anemia

Revision

SDL

PH.1.63- Describe Drug

Regulations, acts and other

legal aspects

SGL (Batch A to H)

--

01-12-21 Wed

CM 4.1.1 Describe various

methods of health education

SDL

MI 8.13 Lab tests SGL --

02-12-21 Thu

PH1.56-Describe basic aspects of

Geriatric and Pediatric

pharmacology. Drug for Geriatric

Pharmacology (1) Lecture

MI 8.6.2 Needle sick injury

SGL--

03-12-21 FriMI 4.2 3 to MI 4.3.4 Mycetoma

and dermatopphyes SDL

PH5.6-Demonstrate ability

to educate public &

patients about various

aspects of drug use

including drug dependence

and OTC drugs

SGL (Batch A to H)

VI-Psychiatry (Nesting)

PH1.62-Describe and

discuss antiseptics and

disinfectants

SGL (Batch A to H)

MI 8.15 Resuls of lab tests

SGL--

04-12-21 Sat MI 8.6.1 BMW SDL

PH1.57-Describe

drugs used in skin

disorders.

Lecture

VI-

Dermatalogy(Nesting)

CM 8.3.16 RMNCH+A

SGL

ffformattive

assesment OG --

1formative

assesment

gynecology 1

MI 3.7.3 Biomarker of

hepatitis virus SGL --

05-12-21 Sun

06-12-21 Mon MI 3.7 to MI 3.8 Hepatitiis viruses SDL

PH1.64-Describe overview

of drug development,

Phases of clinical trials

and Good Clinical Practice

SGL((Batch A to H)

--

07-12-21 Tue

PA 18.2

Laboratory investigation in a case

of leukemia SDL

MI 3.7.4 Biomarkers of

hepatitis virus SGL --

08-12-21 WedCM 8.3.17 INAP

SGL

PA 25.4


including cirrhosis

Revision

SDL

PA 4.1

General features of acute

inflammation - Revision

SGL

PH5.2-Communicate with

the patient regarding

optimal use of a)

drugtherapy,

b) devices and c) storage of

medicines SGL (Batch A to

H)

--

Clinical Posting

Pathology Formative assesment test 8

PH3.2-Perform and interpret a critical appraisal (audit)

of a given

(3) prescription

DOAP (Batch A to H)

Clinical Posting

Clinical Posting

PH3.3-Perform a critical evaluation of the drug

promotional literature(2)

DOAP (Batch A to H)

PH3.8-Communicate effectively with a patient on the

proper use of

prescribed medication

DOAP (Batch A to H)

Clinical PostingPH4.2- Demonstrate the effects of drugs on blood



Clinical Posting

MI 8.7.3 Hand hygience DOAP

HI--Community MEDICINE

VI-- Gen SURGERY

Clinical PostingPA 23.3

Describe and interpret abnormalities in a panel of semen

analysis, thyroid function tests, renal function tests or

Sunday

Clinical Posting

Clinical Posting

Sunday

09-12-21 Thu

PA 28.2.7

Urinary findings in renal failure -

Revision SGL

PH5.4-Explain to the patient

the relationship between

cost of treatment

and patient compliance

SGL (Batch A to H)

VI-Gen.Med.

--

10-12-21 Fri

PA 26.1

Pathology of Pneumonias

Revision SDL

Pathology FAT 8

Feedback--

11-12-21 Sat

PH1.41-Describe the mechanisms


effects,


of uterine relaxants and stimulants

Lecture

VI-Obs Gynae.

CM 15.1 & 15.2 Define

& describe concept of

mental health

&warning signals of

mental health

disorders

LECTURE

FORMATIVE ASSESMENT

MEDICINE -1--

12-12-21 Sun

13-12-21 Mon

PA 27.4 Pathology of

rheumatic heart disease

SDL

Pharmacology

Formative

assesment 6

Feed Back

--

14-12-21 Tue PH1.5 Pharmacodynamic SDLPA 30.1

Carcinoma cervix Revision

SDL

CM 8.3.18 & 15.3 National

Mental Health Programme

SDL

MI 8.4.1 Emerging infectious diseases

Campylobacter SGL--

15-12-21 Wed PH1.30 Anti-arrhythmic drugs 1 LecturePA 28.3 and 28.4

Renal failure - Revision

SGL

CM 13.3 & 13.4 Describe

man made disaster &

national disaster

management authority

SDL

PH1.30 Anti-arrhythmic drugs 2 Lecture --

16-12-21 Thu

PA 28.6

Define and describe the etiology,

pathogenesis….. Of IgA nephropathy

Lecture

PA 30.9

Pathology of endometrial

hyperpplasia

Revision SDL


describe the concept of

disaster management &

Disaster management cycle

SDL

MI 8.4.1 Emerging infectious

diseases Ebola, Marburg SGL--

17-12-21 Fri MI 6.1.5 Chlamydia SGLPH 1.42 Sulfonamides and Co-

trimoxazole SGL--

18-12-21 Sat MI5.2.2 JE encephalitis Lecture

CM 4.2.1 Describe the

methods of

organizing health

promotion and

education activities at

individual, family &

community setting.

SDL

PH 1.42 Aminoglycosides 1

SGL

PA 28.7

Glomerular

manifestattion of

systemic disease Lecture

PA 28.8

Tubulo-interstitial diseases of

kidney SGL

--

19-12-21 Sun

PA 23.3

Describe and interpret abnormalities in a panel of semen

analysis, thyroid function tests, renal function tests or

liver - Revision

DOAP

PH2.2-Prepare oral rehydration solution from ORS

packet and explain its use

DOAP (Batch A to H)




DOAP(Batch A to H)

PA 25.6

Interpret liver function test report and viral hepatitis

serology panel - Revision

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting Pharmacology Formative assesment-6

Clinical PostingPH3.3-Perform a critical evaluation of the drug

promotional literature(3) DOAP (Batch A to H)

Sunday

MI 8.7.2 PPE DOAP

Sunday

20-12-21 MonMI 4.3.2 Atypical mycobacteria

Lecture

FM 2.24.1 to 2.24.3

Describe the clinical features, PM

findings, ML aspects of injuaries

due to physical agents like heat

(heat stroke, heat cramps, etc.)

or cold systemic and localised

hypothermia. Lecure

--

21-12-21 Tue Formative assesment Feedback

PA 28.9

Acute ttubular necrosis

SGL

PH 1.42 Aminoglycosides 2

SGLMI 8.5.1 HAI SGL --

22-12-21 Wed

CM 4.2.2 Describe the methods of

counselling activites at individual,

family & community setting.

SDL

MI 8.5.2 Factors conributing HAI

SGL--

23-12-21 Thu

FM 2.25.1 to 2.25.3

Describe type of injuries C/F,

Pathophysiology, PM findings and

Medicolegal aspects in case of burns,

scalds , lightining, electricution, radiation.

Lecture

MI 2.5.6 Lab diagnosis of

filariasis SGL--

24-12-21 Fri

FM 2.25.4 to 2.25.12 Differentiate

between AM burn and PM burn, Calculate

extent of burn and document and

inerpret PM findings in case of burns,

Lecture

PA 34.3

Pathology of Malignant

Melanoma

SGL

--

25-12-21 Sat

26-12-21 Sun

27-12-21 Mon

28-12-21 Tue

29-12-21 Wed

30-12-21 Thu

31-12-21 Fri

01-01-22 Sat

02-01-22 Sun

03-01-22 Mon

04-01-22 Tue

AETCOM FM 4.16 ,FM 4.17.1

Describe & Discuss Bio-etthics Describe &

Discuss Ethical Principles: Respect for

autonomy,non-malfeasance, beneficence

& jusice. LecturePA 34.1 Pathology of

squamous cell cacinoma

of skin Lecture

PH3.7 Essential drug

list DOAP

FM 1.9.1 & 1.9.2

Importance of documentation

and their importances in

medical practices in regards to

medico legal examinations

SGLCM 11.3 Enumerate and

describe the occupational

health hazards their risk

factors and preventive

measures LECTURE

--

05-01-22 WedCM 8.3.15 RBSK

SGL

FORMATIVE ASSESMENT

MEDICINE 2

FM FM FM--

06-01-22 Thu FM FM --

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

Clinical Posting

PA 34.4 Common

tumours of skin DOAP

Christmas

IIIrd Terminal

PH 2.2 Prepre ORS packet DOAP

PH 2.3 Setting up of IV drip set DOAP

PH 2.4 Calculattion of drug dosages DOAP

PH 1.12 calculatioin of drug dosages using appropriate

formulae DOAP

MI 5.3.2 Meningitis LCB DOAP

PH2.4 calculation of drug dosage DOAP

Clinical Posting

Sunday

07-01-22 Fri

FM

FORMATIVE ASSESMENT OG-2

CM 4.1.2 Advantages

and limitations of

health education

methods

SDL

FM FM

--

08-01-22 Sat --09-01-22 Sun

10-01-22 Mon

11-01-22 Tue

12-01-22 Wed

13-01-22 Thu --14-01-22 Fri --15-01-22 Sat --16-01-22 Sun

17-01-22 Mon

18-01-22 Tue

19-01-22 Wed

20-01-22 Thu

21-01-22 Fri

22-01-22 Sat

23-01-22 Sun

24-01-22 Mon --25-01-22 Tue --26-01-22 Wed --27-01-22 Thu

28-01-22 Fri

29-01-22 Sat

30-01-22 Sun

Subjects Lectures

(hours)

Small group Teaching /

Tutorials

Integrated learning practical

(hours)

Self directed learning

(hours)

Total

(hours)

COMMUNITY MEDICINE 20 30 10 60

PATHOLOGY 80 140 12 232

MICROBIOLOGY 74 115 11 200

PHARMACOLOGY 80 138 12 230

SURGERY 25 -- -- 25

MEDICINE 27 -- -- 27

OBS & GYNAECOLOGY 25 -- -- 25

CLINICAL POSTING -- -- 540

AETCOM 37 -- -- 37

Sports and Extra-curricular activities 37 -- -- 37

FORENSIC MEDICINE 15 30 5 50

Pandemic Module -- 28TOTAL -- -- -- 1491

Copy to :- Prof. M.Z. Idris

Director- Hospital Dean/DirectorIMS&R,

All HODs, IIMSR Integral University, Lucknow

Medical Education Unit

Remedial

Professional

Professional Practical

PH 3.4 Recognize and report an ADR DOAP

Sunday

Sunday

Sunday

INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, … · 2021. 3. 1. · INTEGRAL INSTITUTE OF...

Documents

Transcript of INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, … · 2021. 3. 1. · INTEGRAL INSTITUTE OF...